BLOOD CANCER UNITED INC: Form 990, tax year 2009
View the entire original 990 at ProPublica ↗
- Organization
- BLOOD CANCER UNITED INC (EIN 13-5644916)
- Tax period
- 2009-07-01 to 2010-06-30
- Filed
- 2011-02-03
- IRS object ID
- 201110349349301101
- Schema version
- 2009v1.3
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule L
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Timestamp | 2011-02-03T12:14:26-06:00 | Timestamp |
| Tax Period End Date | 2010-06-30 | TaxPeriodEndDate |
Preparer Firm PreparerFirm
Preparer Firm Business Name PreparerFirmBusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KPMG LLP | BusinessNameLine1 |
Preparer Firm US Address PreparerFirmUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 345 PARK AVENUE | AddressLine1 |
| City | NEW YORK | City |
| State | NY | State |
| ZIP Code | 101540102 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnType |
| Tax Period Begin Date | 2009-07-01 | TaxPeriodBeginDate |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 135644916 | EIN |
Name Name
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | THE LEUKEMIA & LYMPHOMA SOCIETYINC | BusinessNameLine1 |
| Business Name Line2 | INC | BusinessNameLine2 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Control | LEUK | NameControl |
| Phone | 9149495213 | Phone |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1311 MAMARONECK AVENUE | AddressLine1 |
| Address Line2 | ROOM/SUITE 310 | AddressLine2 |
| City | WHITE PLAINS | City |
| State | NY | State |
| ZIP Code | 10605 | ZIPCode |
Officer Officer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | JAMES T NANGLE | Name |
| Title | SENIOR VICE PRESIDENT & CFO | Title |
| Phone | 9149495213 | Phone |
| Date Signed | 2011-02-03 | DateSigned |
| Authorize Third Party | true | AuthorizeThirdParty |
Preparer Preparer
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name | KPMG LLP | Name |
| Phone | 2127589700 | Phone |
| Date Prepared | 2011-02-03 | DatePrepared |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax Year | 2009 | TaxYear |
| Build TS | 2016-02-24 21:20:13Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Of Principal Officer Person | JOHN WALTER | NameOfPrincipalOfficerPerson |
Address Principal Officer US AddressPrincipalOfficerUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1311 MAMARONECK AVENUE | AddressLine1 |
| City | WHITE PLAINS | City |
| State | NY | State |
| ZIP Code | 10605 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | 396255432 | GrossReceipts |
| Group Return For Affiliates | false | GroupReturnForAffiliates |
| Organization501c | X | Organization501c |
| Web Site | WWW.LLS.ORG | WebSite |
| Type Of Organization Corporation | X | TypeOfOrganizationCorporation |
| Year Formation | 1949 | YearFormation |
| State Legal Domicile | NY | StateLegalDomicile |
| Activity Or Mission Description | THE LEUKEMIA & LYMPHOMA SOCIETY'S MISSION IS TO CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF PATIENTS AND THEIR FAMILIES. | ActivityOrMissionDescription |
| Nbr Voting Members Governing Body | 33 | NbrVotingMembersGoverningBody |
| Nbr Independent Voting Members | 31 | NbrIndependentVotingMembers |
| Total Nbr Employees | 2087 | TotalNbrEmployees |
| Total Nbr Volunteers | 3000000 | TotalNbrVolunteers |
| Total Gross UBI | -6739 | TotalGrossUBI |
| Contributions Grants Prior Year | 268661802 | ContributionsGrantsPriorYear |
| Contributions Grants Current Year | 238276411 | ContributionsGrantsCurrentYear |
| Program Service Revenue CY | 0 | ProgramServiceRevenueCY |
| Investment Income Prior Year | 5638674 | InvestmentIncomePriorYear |
| Investment Income Current Year | 5945189 | InvestmentIncomeCurrentYear |
| Other Revenue Prior Year | 3477294 | OtherRevenuePriorYear |
| Other Revenue Current Year | 2522446 | OtherRevenueCurrentYear |
| Total Revenue Prior Year | 277777770 | TotalRevenuePriorYear |
| Total Revenue Current Year | 246744046 | TotalRevenueCurrentYear |
| Grants And Similar Amnts Prior Year | 90994934 | GrantsAndSimilarAmntsPriorYear |
| Grants And Similar Amnts CY | 85577867 | GrantsAndSimilarAmntsCY |
| Benefits Paid To Members CY | 0 | BenefitsPaidToMembersCY |
| Salaries Etc Prior Year | 88469224 | SalariesEtcPriorYear |
| Salaries Etc Current Year | 81834903 | SalariesEtcCurrentYear |
| Total Prof Fundrsng Exp Prior Year | 9542900 | TotalProfFundrsngExpPriorYear |
| Total Prof Fundrsng Exp CY | 9299646 | TotalProfFundrsngExpCY |
| Total Fundrsng Exp Current Year | 44205434 | TotalFundrsngExpCurrentYear |
| Other Expense Prior Year | 74131495 | OtherExpensePriorYear |
| Other Expenses Current Year | 73769925 | OtherExpensesCurrentYear |
| Total Expenses Prior Year | 263138553 | TotalExpensesPriorYear |
| Total Expenses Current Year | 250482341 | TotalExpensesCurrentYear |
| Revenues Less Expenses Prior Year | 14639217 | RevenuesLessExpensesPriorYear |
| Revenues Less Expenses CY | -3738295 | RevenuesLessExpensesCY |
| Total Assets BOY | 217104128 | TotalAssetsBOY |
| Total Assets EOY | 221660340 | TotalAssetsEOY |
| Total Liabilities BOY | 114241808 | TotalLiabilitiesBOY |
| Total Liabilities EOY | 112213271 | TotalLiabilitiesEOY |
| Net Assets Or Fund Balances BOY | 102862320 | NetAssetsOrFundBalancesBOY |
| Net Assets Or Fund Balances EOY | 109447069 | NetAssetsOrFundBalancesEOY |
| Mission Description | THE LEUKEMIA & LYMPHOMA SOCIETY'S MISSION IS TO CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF PATIENTS AND THEIR FAMILIES. | MissionDescription |
| Significant New Program Services | false | SignificantNewProgramServices |
| Significant Change | false | SignificantChange |
| Expense | 68144902 | Expense |
| Grants | 65515876 | Grants |
| Description | A) RESEARCH PROGRAMS: WITH ADVISORY INPUT FROM RECOGNIZED BIOMEDICAL RESEARCH EXPERTS, LLS FUNDS EXEMPLARY PROJECTS ACROSS THE ENTIRE RESEARCH CONTINUUM RELEVANT TO IMPROVED OUTCOMES FOR BLOOD CANCER PATIENTS, FROM BASIC LABORATORY SCIENCE THROUGH CLINICAL TRIALS, AND FROM INVESTIGATOR-INITIATED RESEARCH TO PRIVATE-SECTOR DRUG DEVELOPMENT ALLIANCES. LLS IS DELIBERATE AND PURPOSEFUL IN FINDING AND SUPPORTING RESEARCH THAT IS MOST LIKELY TO HELP PATIENTS, AS SOON AS POSSIBLE. (CONTINUED ON SCHEDULE O) TO DATE, LLS HAS INVESTED MORE THAN 750 MILLION IN RESEARCH AIMED AT HELPING ALL BLOOD CANCER PATIENTS LIVE LONGER, HEALTHY LIVES. WE WILL CONTINUE TO SUPPORT RESEARCH THROUGH OUR INNOVATIVE AND INTEGRATED FUNDING PROGRAMS, UNTIL EVERY PATIENT HAS A SAFE AND EFFECTIVE THERAPY. IN FISCAL YEAR 2010, LLS SUPPORTED RESEARCH IN THE U.S., CANADA, AND 9 OTHER COUNTRIES.RESEARCH FUNDING WAS DISPERSED ACROSS ALL BLOOD CANCER CATEGORIES, INCLUDING: LEUKEMIA RESEARCH: APPROXIMATELY 25 MILLION LYMPHOMA RESEARCH: APPROXIMATELY 18 MILLION THERAPY ACCELERATION: APPROXIMATELY 8 MILLION BASIC BIOLOGY: APPROXIMATELY 6 MILLION MYELOMA RESEARCH: APPROXIMATELY 4 MILLION IMMUNOTHERAPY: APPROXIMATELY 4 MILLION STEM CELL: APPROXIMATELY 1 MILLION OUR CRITICAL ROLE LLS PROGRAMS ACCELERATE RELEVANT RESEARCH OUTCOMES BY: -BUILDING A FOCUSED RESEARCH WORK-FORCE: ASSURING THE NEXT ROUND OF BREAKTHROUGHS REQUIRES THAT YOUNG INVESTIGATORS BE ENCOURAGED TO WORK IN THE BLOOD CANCER RESEARCH FIELD. -TURNING DISCOVERIES INTO CLINICAL PROGRESS: BASIC SCIENCE DISCOVERIES MUST BE TRANSLATED INTO NEW, SAFE AND EFFECTIVE TREATMENTS THAT CAN ULTIMATELY PROLONG AND ENHANCE PATIENT LIVES. -SUPPORTING SYNERGY: LARGE GRANTS AND CONTRACTS ENABLE SCIENTISTS IN ACADEMIA AND THE PRIVATE-SECTOR TO COLLABORATE, COMBINING RESOURCES AND EXPERTISE TO PRODUCE MORE AND FASTER ADVANCES. -FILLING A VOID: RESEARCH PROJECTS THAT ARE HIGH-RISK OR ADDRESS RARE CANCERS ARE LESS LIKELY TO BE FUNDED BY THE GOVERNMENT OR BY FOR-PROFIT COMPANIES. LLS SUPPORTS MANY PROMISING PROJECTS THAT MIGHT OTHERWISE NEVER PROVIDE ADVANCES FOR THE BLOOD CANCER PATIENTS WHO NEED THEM. -INCREASING ACCESS TO CLINICAL TRIALS: PARTNERING WITH LEADING CLINICAL TRIAL CENTERS CAN ACCELERATE THE CLINICAL TESTING OF NEW BLOOD CANCER THERAPIES THAT ARE OFTEN A PATIENT'S BEST CHANCE FOR CURE. LLS ADMINISTERS TWO INTEGRATED RESEARCH FUNDING PROGRAMS, THE RESEARCH GRANT PROGRAM AND THE THERAPY ACCELERATION PROGRAM, TO SUPPORT OUR MISSION: CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF PATIENTS AND THEIR FAMILIES. THE RESEARCH GRANT PROGRAM PROVIDES GRANT FUNDING TO SUPPORT SCIENTIFIC STUDIES AT ACADEMIC CENTERS AROUND THE WORLD, THROUGH THREE GRANT MECHANISMS: 1.THE CAREER DEVELOPMENT PROGRAM PROVIDES STIPENDS TO INVESTIGATORS OF EXCEPTIONAL PROMISE IN THE EARLY STAGES OF THEIR CAREERS, HELPING THEM TO DEVOTE THEIR CAREERS TO LEUKEMIA, LYMPHOMA AND/OR MYELOMA RESEARCH. SCHOLAR GRANTS ARE AWARDED AT 110,000 PER YEAR FOR A TOTAL OF 550,000 OVER FIVE YEARS. SPECIAL FELLOW GRANTS ARE AWARDED AT 65,000 PER YEAR FOR A TOTAL OF 195,000 OVER THREE YEARS. FELLOW GRANTS ARE AWARDED AT 55,000 PER YEAR FOR A TOTAL OF 165,000 OVER THREE YEARS. 2. THE TRANSLATIONAL RESEARCH PROGRAM SUPPORTS OUTSTANDING INVESTIGATIONS DEEMED BY OUR EXPERT ADVISORS MOST LIKELY TO TRANSLATE BASIC BIOMEDICAL DISCOVERIES INTO NEW, SAFE AND EFFECTIVE TREATMENTS, ULTIMATELY PROLONGING AND ENHANCING PATIENTS' LIVES. TRANSLATIONAL RESEARCH AWARDS ARE MADE FOR AN INITIAL THREE-YEAR PERIOD. AWARDS UP TO 200,000 PER YEAR FOR THREE YEARS, FOR A TOTAL OF 600,000 ARE GRANTED EACH YEAR. FUNDING FOR AN ADDITIONAL TWO YEARS MAY BE PROVIDED FOR HIGHLY PROMISING PROJECTS THAT ARE ENTERING PHASE I CLINICAL TRIAL. 3. THE SPECIALIZED CENTER OF RESEARCH PROGRAM ENCOURAGES MULTIDISCIPLINARY RESEARCH BY TEAMS OF LEADING-EDGE ACADEMIC INVESTIGATORS THAT HASTENS THE DISCOVERY AND DEVELOPMENT OF BETTER TREATMENTS FOR LEUKEMIA, LYMPHOMA AND MYELOMA PATIENTS. A CENTER IS COMPOSED OF AT LEAST THREE INDEPENDENT RESEARCH PROGRAMS THAT ARE INTEGRATED AND SUPPORTED BY SCIENTIFIC CORE LABORATORIES. EACH SPECIALIZED CENTER OF RESEARCH IS FUNDED UP TO 1.25 MILLION ANNUALLY OVER A FIVE-YEAR PERIOD, TO A TOTAL COST OF 6.25 MILLION. APPLICATION REVIEW PROCESS SCIENTISTS AND PHYSICIAN SCIENTISTS WHO ARE EXPERTS IN THE FIELD OF LEUKEMIA, LYMPHOMA, AND MYELOMA RESEARCH CAREFULLY EVALUATE ALL GRANT APPLICATIONS. GUIDELINES, INSTRUCTIONS, AND APPLICATIONS FOR LLS'S THREE RESEARCH PROGRAMS MAY BE OBTAINED BY VISITING WWW.LLS.ORG. THE THERAPY ACCELERATION PROGRAM (TAP) IS A STRATEGIC LLS INITIATIVE LAUNCHED IN 2007 WITH 4 MILLION IN SEED FUNDING. THIS PROGRAM PROMISES TO ACCELERATE NEW AND BETTER TREATMENTS AND CLINICAL TESTS INTO PRECLINICAL DEVELOPMENT AND CLINICAL TRIALS. WORKING IN CONCERT WITH ACADEMIC INVESTIGATORS, MEDICAL CENTERS, AND COMPANIES, TAP IS FURTHER BRIDGING THE GAP BETWEEN DISCOVERY AND HUMAN APPLICATIONS TO INCREASE THE LIKELIHOOD THAT NOVEL, POSSIBLY BREAKTHROUGH, TREATMENTS WILL BE MADE AVAILABLE TO PATIENTS AS SOON AS POSSIBLE. TAP ENCOMPASSES THREE INNOVATIVE EFFORTS: 1.THE ACADEMIC CONCIERGE DIVISION IDENTIFIES CURRENT LLS-FUNDED RESEARCH WITH THE GREATEST CLINICAL PROMISE AND PROVIDES THE FUNDING AND SUPPORT NEEDED TO ADVANCE SELECTED PROJECTS TO THE PRODUCT STAGE. 2.THE CLINICAL TRIAL DIVISION PARTNERS LLS WITH CERTAIN OF THE COUNTRY'S LEADING CLINICAL TRIAL CENTERS TO ACCELERATE THE TESTING OF NEW BLOOD CANCER THERAPIES IN CLINICAL TRIALS. 3.THE BIOTECHNOLOGY ACCELERATOR DIVISION ALLIES LLS WITH COMPANIES TO COMBINE SCIENTIFIC AND FINANCIAL RESOURCES AND ACCELERATE THE DEVELOPMENT OF POTENTIAL THERAPIES WHICH WOULDN'T OTHERWISE BE PRIORITIZED BY THE COMPANY. APPLICATION REVIEW PROCESS ALL THERAPY ACCELERATION PROJECTS ARE REVIEWED AND APPROVED BY A VOLUNTEER PANEL INCLUDING MEDICAL, SCIENTIFIC, BUSINESS, AND INTELLECTUAL PROPERTY LAW EXPERTS. FUNDING IS GOVERNED BY A CONTRACT WITH EXPLICIT TIMELINES, MILESTONES, AND GO/NO GO DECISION POINTS, WHICH ALSO CONTEMPLATES A RETURN ON INVESTMENT FOR LLS. GUIDELINES, INSTRUCTIONS, AND APPLICATIONS FOR THE THERAPY ACCELERATION PROGRAM MAY BE OBTAINED BY VISITING WWW.LLS.ORG. | Description |
Activity2 Activity2
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 73274140 | Expense |
| Grants | 20061991 | Grants |
| Description | B) PATIENT & COMMUNITY SERVICES : AN ESTIMATED 957,902 PEOPLE ACROSS THE UNITED STATES (US) CURRENTLY BATTLE LEUKEMIA, LYMPHOMA AND MYELOMA. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) OFFERS THE MOST COMPREHENSIVE ARRAY OF SERVICES TO BLOOD CANCER PATIENTS AND THEIR FAMILIES. LAST YEAR ALONE, LLS MADE 4.7 MILLION CONTACTS WITH PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS. (CONTINUED ON SCHEDULE O) -TELECONFERENCES & WEBCASTS: LLS SPONSORS TELECONFERENCES AND WEB CASTS FOR PATIENTS, CAREGIVERS, SURVIVORS AND HEALTH CARE PROFESSIONALS ON LEUKEMIA, LYMPHOMA, MYELOMA AND MYELODYSPLASTIC SYNDROMES. A CALENDAR OF THESE FREE EVENTS AND ARCHIVES OF PAST EVENTS ARE AVAILABLE IN THE "NATIONAL EDUCATION PROGRAMS" SECTION OF WWW.LLS.ORG. 438,105 TELEPHONE AND WEB-BASED PROGRAM PARTICIPANTS IN 2010 -EDUCATIONAL MATERIALS: AN EXTENSIVE COLLECTION OF EDUCATIONAL MATERIALS IS OFFERED FREE-OF-CHARGE TO PATIENTS AND HEALTH CARE PROFESSIONALS. EACH YEAR, LLS DISTRIBUTES BOOKLETS, BROCHURES, FACT SHEETS AND DVDS THROUGH THE INFORMATION RESOURCE CENTER AND LOCAL LLS CHAPTERS. 1,207,000 PRINTED BOOKLETS, BROCHURES, FACT SHEETS AND DVDS DISTRIBUTED IN 2010 MANY MATERIALS ARE ALSO AVAILABLE TO VIEW AND DOWNLOAD AT WWW.LLS.ORG/FREEMATERIALS. DOWNLOADABLE MATERIALS ARE AVAILABLE IN ENGLISH,SPANISH AND FRENCH. -CHAPTER-BASED PROGRAMS: EACH LLS CHAPTER IS STAFFED WITH A PATIENT SERVICES MANAGER WHO OVERSEES THE CHAPTER'S SERVICES TO PATIENTS AND THEIR FAMILIES. PATIENT SERVICES MANAGERS ARE HEALTHCARE PROFESSIONALS, OFTEN WITH A BACKGROUND IN ONCOLOGY NURSING OR SOCIAL WORK. -COMMUNITY BASED EDUCATION: 42,848 PATIENT AND CAREGIVER PARTICIPANTS IN 2010 11,953 HEALTHCARE PROFESSIONAL PARTICIPANTS IN 2010 EACH OF THE FOLLOWING FOUR PROGRAMS ARE OFFERED THROUGH ALL OF OUR CHAPTERS. 1.NEW DIRECTIONS IN BLOOD CANCER THERAPIES THIS PROGRAM PROVIDES PATIENTS, FAMILIES AND HEALTHCARE PROFESSIONALS WITH A CLEAR DESCRIPTION OF WHAT CLINICAL TRIALS ARE, HOW CANCER DRUGS ARE DEVELOPED, AND WHAT THE EMERGING TREATMENT OPTIONS ARE FOR LEUKEMIA, LYMPHOMA,AND MYELOMA. 2.LIVING WITH MYELOMA: AN OVERVIEW OF DIAGNOSIS AND TREATMENT THIS PROGRAM PROVIDES PATIENTS, FAMILY MEMBERS AND CAREGIVERS WITH THE LATEST INFORMATION ON MYELOMA AND MYELOMA THERAPY, INCLUDING A QUESTION AND ANSWER SESSION WITH A MEDICAL EXPERT IN THEIR COMMUNITY. 3.GETTING THE BEST CANCER CARE AT AGE 55 AND OLDER THIS EDUCATION PROGRAM PRESENTS AN OVERVIEW OF THE MANY FACTORS, NOT AGE ALONE, THAT HEALTHCARE PROFESSIONALS SHOULD ASSESS TO DETERMINE AN APPROPRIATE CANCER TREATMENT PLAN FOR AN OLDER ADULT. 4.WELCOME BACK: FACILITATING THE SCHOOL EXPERIENCE FOR CHILDHOOD CANCER SURVIVOR THIS EDUCATION PROGRAM DISCUSSES POSSIBLE EMOTIONAL AND COGNITIVE SHORT- AND LONG-TERM EFFECTS THAT CHILDREN MAY EXPERIENCE AFTER TREATMENT, AND OFFERS NUMEROUS RESOURCES THAT CAN ASSIST CHILDHOOD CANCER SURVIVORS TO FLOURISH IN THE SCHOOL POST TREATMENT. -SUPPORT SERVICES: 1.FAMILY SUPPORT GROUPS LLS HAS DEVELOPED NEARLY 531 FAMILY SUPPORT GROUPS AT CHAPTERS THROUGHOUT THE US AND CANADA. LLS ALSO HAS MORE THAN 930 VOLUNTEER SUPPORT GROUP FACILITATORS WITH BACKGROUNDS IN ONCOLOGY NURSING OR SOCIAL WORK. GROUPS ARE GUIDED BY TWO VOLUNTEER ONCOLOGY HEALTH PROFESSIONALS, AND PROVIDE INFORMATION AND SUPPORT, AND ENCOURAGE GREATER COMMUNICATION AMONG PATIENTS, FAMILIES, FRIENDS AND HEALTH CARE PROFESSIONALS. 10,420 PARTICIPANTS IN FAMILY SUPPORT GROUPS IN 2010 2.FIRST CONNECTION FIRST CONNECTION IS A PROGRAM THAT LINKS NEWLY DIAGNOSED PATIENTS TO A PEER VOLUNTEER WHO HAS EXPERIENCED A SIMILAR DIAGNOSIS. A TRAINED PATIENT-VOLUNTEER CURRENTLY IN REMISSION CONTACTS THE NEW PATIENT TO SHARE INFORMATION AND SUPPORT. THIS PROGRAM IS AVAILABLE THROUGH LLS CHAPTERS. 5,376 FIRST CONNECTIONS IN 2010 3.PATIENT FINANCIAL AID PROGRAM FOR MORE THAN 45 YEARS, LLS HAS HELPED PATIENTS DEMONSTRATING SIGNIFICANT NEED TO OBTAIN FINANCIAL ASSISTANCE TO COVER A PORTION OF THEIR TREATMENT COSTS. THE LLS PATIENT FINANCIAL AID PROGRAM OFFERS 150 PER YEAR TO THOSE WITH A CONFIRMED BLOOD CANCER DIAGNOSIS IN ACTIVE TREATMENT OR ONGOING FOLLOW-UP. PATIENT FINANCIAL AID FUNDS ARE SUBJECT TO AVAILABILITY. 40,392 PATIENT FINANCIAL AID RECIPIENTS IN 2010 4.CO-PAY ASSISTANCE PROGRAM THIS ASSISTANCE PROGRAM HELPS PATIENTS WITH MANY KINDS OF BLOOD CANCERS MEET THEIR HEALTH INSURANCE OR MEDICARE PLAN PART B OR D PREMIUMS OR CO-PAYMENT OBLIGATIONS RELATED TO TREATING THEIR CANCER. PATIENTS WITH PRESCRIPTION DRUG COVERAGE, MEDICARE BENEFICIARIES UNDER MEDICARE PART B AND/OR MEDICARE PART D, MEDICARE SUPPLEMENTARY HEALTH INSURANCE OR MEDICARE ADVANTAGE SHOULD CHECK WITH LLS TO SEE IF THEY MEET ELIGIBILITY REQUIREMENTS TO RECEIVE FINANCIAL SUPPORT. CO-PAY ASSISTANCE IS SUBJECT TO FUND AVAILABILITY BY SPECIFIC BLOOD CANCER DIAGNOSIS. FOR MORE INFORMATION CALL, (877) LLS-COPAY (877) 557-2672 OR VISIT WWW.LLS.ORG/COPAY. 5536 PATIENTS RECEIVED LLS CO-PAY ASSISTANCE IN 2010 5.THE TRISH GREENE BACK TO SCHOOL PROGRAM FOR CHILDREN WITH CANCER THIS PROGRAM IS DESIGNED TO INCREASE COMMUNICATION AMONG HEALTH CARE PROFESSIONALS, PARENTS, PATIENTS AND SCHOOL PERSONNEL TO ASSURE YOUNGSTERS A SMOOTH TRANSITION FROM ACTIVE TREATMENT BACK TO SCHOOL. PRINTED LITERATURE, VIDEOS AND OTHER MATERIALS TO AID THE PROCESS ARE AVAILABLE THROUGH ALL LOCAL CHAPTERS, INCLUDING: -WELCOME BACK: FACILITATING THE SCHOOL EXPERIENCE FOR CHILDHOOD CANCER SURVIVORS CHAPTER EDUCATION PROGRAM. THIS EDUCATION PROGRAM FOR SCHOOL PERSONNEL AND PARENTS DISCUSSES POSSIBLE EMOTIONAL AND COGNITIVE LATE EFFECTS OF CANCER TREATMENT IN CHILDREN AND OFFERS NUMEROUS RESOURCES THAT CAN ASSIST CHILDHOOD CANCER SURVIVORS TO FLOURISH IN THE SCHOOL ENVIRONMENT POST-TREATMENT. IN FISCAL YEAR 2010 2,609 SCHOOL PERSONNEL, HEALTHCARE PROFESSIONALS AND PARENTS PARTICIPATED IN THE 67 WELCOME BACK PROGRAMS ACROSS THE USA AND CANADA. -LEARNING AND LIVING WITH CANCER,ADVOCATING FOR YOUR CHILD'S EDUCATIONAL NEEDS: THIS BOOKLET OFFERS PARENTS INFORMATION ON THE LEARNING CHALLENGES CHILDREN MAY FACE DURING AND AFTER CANCER TREATMENT, LAWS THAT PROTECT THE EDUCATIONAL NEEDS OF CHILDREN WITH CANCER AND SPECIFIC WAYS THAT SCHOOLS CAN HELP MEET A CHILD'S EDUCATIONAL NEEDS. | Description |
Activity3 Activity3
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 36746427 | Expense |
| Description | C) PUBLIC HEALTH EDUCATION: INFORMATION AND EDUCATION NATIONAL PROGRAMS: INFORMATION RESOURCE CENTER THE INFORMATION RESOURCE CENTER (IRC) PROVIDES INFORMATION AND RESOURCES USEFUL TO PATIENTS, THEIR FAMILIES AND HEALTH CARE PROFESSIONALS, AND IS STAFFED BY MASTER'S LEVEL ONCOLOGY SOCIAL WORKERS, NURSES AND HEALTH EDUCATORS. (CONTINUED ON SCHEDULE O) FACT SHEETS FOR FREQUENTLY ASKED QUESTIONS AND A REFERRAL DATABASE TO OTHER HELPING ORGANIZATIONS ARE AVAILABLE. PATIENTS, FAMILIES AND PROFESSIONALS MAY CALL THE INFORMATION RESOURCE CENTER TOLL-FREE NUMBER AT (800) 955-4572 MONDAY THROUGH FRIDAY, 9 A.M. TO 6 P.M., ET OR EMAIL TO INFOCENTER@LLS.ORG. 77,159 INQUIRIES IN 2010 TRANSLATION SERVICES AVAILABLE IN MORE THAN 165 LANGUAGES ONLINE ENGAGEMENT THE LLS WEBSITE SERVES A WIDE VARIETY OF EDUCATION AND INFORMATION NEEDS. USERS CAN PERSONALIZE THEIR LLS WEB PAGES TO KEEP CURRENT WITH DISEASE SPECIFIC UPDATES AND LOCAL CHAPTER EDUCATION, SUPPORT AND EVENT ACTIVITIES. THE SITE FEATURES A COMPREHENSIVE OVERVIEW OF LLS PROGRAMS AND SERVICES, FAMILY SUPPORT GROUP LOCATIONS, INFORMATION ABOUT OUR PEER-TO-PEER PROGRAM "FIRST CONNECTION", AND OTHER PROGRAMS. PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS CAN INTERACT WITH LLS IN CONVENIENT AND PERSONAL WAYS THROUGH SOCIAL NETWORKING, PODCASTS AND ENEWSLETTERS. 3.6 MILLION UNIQUE VISITS TO PATIENT SERVICES/DISEASE INFORMATION PAGES IN 2010 176,847 ENEWSLETTER SUBSCRIBERS 113,493 BLOOD CANCER DISCUSSION BOARDS UNIQUE VISITS 103,994 TELECONFERENCE PODCASTS DOWNLOADS | Description |
Activity Other ActivityOther
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | 7863476 | Expense |
| Description | D) PROFESSIONAL EDUCATION: LLS ALSO SERVES THE EDUCATIONAL NEEDS OF THE MEDICAL AND RESEARCH COMMUNITY THROUGH A NUMBER OF PROFESSIONAL EDUCATION SYMPOSIA OFFERED THROUGHOUT THE YEAR. THE EDUCATIONAL PROGRAM OFFERS VARYING FORMATS TO FACILITATE THE EXCHANGE OF INFORMATION AND IDEAS ON THE NEWEST DEVELOPMENTS IN CANCER RESEARCH AND TREATMENT. | Description |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Other Program Service Exp | 7863476 | TotalOfOtherProgramServiceExp |
| Total Program Service Expense | 186028945 | TotalProgramServiceExpense |
| Described In501 C3 | true | DescribedIn501C3 |
| Schedule B Required | true | ScheduleBRequired |
| Political Activities | false | PoliticalActivities |
| Lobbying Activities | true | LobbyingActivities |
| Donor Advised Funds | false | DonorAdvisedFunds |
| Conservation Easements | false | ConservationEasements |
| Collections Of Art | true | CollectionsOfArt |
| Credit Counseling | false | CreditCounseling |
| Term Or Permanent Endowments | true | TermOrPermanentEndowments |
| Balance Sheet Amounts Reported | true | BalanceSheetAmountsReported |
| Independent Audit Financial Stmt | false | IndependentAuditFinancialStmt |
| Consolidated Audit Financial Stmt | true | ConsolidatedAuditFinancialStmt |
| School | false | School |
| Foreign Office | true | ForeignOffice |
| Foreign Activities | true | ForeignActivities |
| More Than5000 K To Organizations | true | MoreThan5000KToOrganizations |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividuals |
| Professional Fundraising | true | ProfessionalFundraising |
| Fundraising Activities | true | FundraisingActivities |
| Gaming | true | Gaming |
| Hospital | false | Hospital |
| Grants To Organizations | true | GrantsToOrganizations |
| Grants To Individuals | true | GrantsToIndividuals |
| Schedule J Required | true | ScheduleJRequired |
| Tax Exempt Bonds | false | TaxExemptBonds |
| Excess Benefit Transaction | false | ExcessBenefitTransaction |
| Prior Excess Benefit Transaction | false | PriorExcessBenefitTransaction |
| Loan To Officer Or DQP | false | LoanToOfficerOrDQP |
| Grant To Related Person | true | GrantToRelatedPerson |
| Bsnss Rltnshp With Organization | false | BsnssRltnshpWithOrganization |
| Bsnss Rltnshp Thru Family Member | false | BsnssRltnshpThruFamilyMember |
| Officer Entity With Bsnss Rltnshp | true | OfficerEntityWithBsnssRltnshp |
| Deductible Non Cash Contributions | true | DeductibleNonCashContributions |
| Deductible Contributions Of Art | false | DeductibleContributionsOfArt |
| Terminated | false | Terminated |
| Partial Liquidation | false | PartialLiquidation |
| Disregarded Entity | false | DisregardedEntity |
| Related Entity | true | RelatedEntity |
| Related Org Controlled Entity | true | RelatedOrgControlledEntity |
| Transfers To Exempt Non Chrtbl Org | false | TransfersToExemptNonChrtblOrg |
| Activities Conducted Partnership | false | ActivitiesConductedPartnership |
| Schedule O Required | true | ScheduleORequired |
| Number Forms Transmitted With1096 | 1152 | NumberFormsTransmittedWith1096 |
| Number W2 G Included | 40 | NumberW2GIncluded |
| Compliance With Backup Witholding | true | ComplianceWithBackupWitholding |
| Number Of Employees | 2087 | NumberOfEmployees |
| Employment Tax Returns Filed | true | EmploymentTaxReturnsFiled |
| Unrelated Business Income | true | UnrelatedBusinessIncome |
| Form990-T Filed | true | Form990-TFiled |
| Foreign Financial Account | true | ForeignFinancialAccount |
| Name Of Foreign Country | CA | NameOfForeignCountry |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTrans |
| Taxable Party Notification | false | TaxablePartyNotification |
| Non Deductible Contributions | true | NonDeductibleContributions |
| Non Deductible Disclosure | true | NonDeductibleDisclosure |
| Quid Pro Quo Contributions | true | QuidProQuoContributions |
| Quid Pro Quo Disclosure | true | QuidProQuoDisclosure |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOf |
| Funds To Pay Premiums | false | FundsToPayPremiums |
| Premiums Paid | false | PremiumsPaid |
| Nbr Voting Governing Body Members | 33 | NbrVotingGoverningBodyMembers |
| Number Independent Voting Members | 31 | NumberIndependentVotingMembers |
| Family Or Business Relationship | false | FamilyOrBusinessRelationship |
| Delegation Of Management Duties | false | DelegationOfManagementDuties |
| Changes To Organizing Docs | false | ChangesToOrganizingDocs |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuse |
| Members Or Stockholders | true | MembersOrStockholders |
| Election Of Board Members | true | ElectionOfBoardMembers |
| Decisions Subject To Approval | true | DecisionsSubjectToApproval |
| Minutes Of Governing Body | true | MinutesOfGoverningBody |
| Minutes Of Committees | true | MinutesOfCommittees |
| Officer Mailing Address | false | OfficerMailingAddress |
| Local Chapters | true | LocalChapters |
| Policies Reference Chapters | true | PoliciesReferenceChapters |
| Form990 Provided To Governing Body | true | Form990ProvidedToGoverningBody |
| Conflict Of Interest Policy | true | ConflictOfInterestPolicy |
| Annual Disclosure Covered Persons | true | AnnualDisclosureCoveredPersons |
| Regular Monitoring Enforcement | true | RegularMonitoringEnforcement |
| Whistleblower Policy | true | WhistleblowerPolicy |
| Document Retention Policy | true | DocumentRetentionPolicy |
| Compensation Process CEO | true | CompensationProcessCEO |
| Compensation Process Other | true | CompensationProcessOther |
| Investment In Joint Venture | false | InvestmentInJointVenture |
| States Where Copy Of Return Is Filed | AK | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AR | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | AZ | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | CA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | CT | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | DE | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | FL | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | GA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | IL | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | IN | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | KS | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | KY | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | LA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MD | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | ME | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MN | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MO | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | MS | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NH | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NJ | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NM | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NV | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | NY | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OH | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OK | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | OR | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | PA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | PR | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | RI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | SC | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | TN | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | UT | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | VA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WA | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WI | StatesWhereCopyOfReturnIsFiled |
| States Where Copy Of Return Is Filed | WV | StatesWhereCopyOfReturnIsFiled |
| Own Website | X | OwnWebsite |
| Upon Request | X | UponRequest |
The Books Are In Care Of TheBooksAreInCareOf
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Person | JAMES T NANGLE CFO | NamePerson |
| Telephone Number | 9149495213 | TelephoneNumber |
Address US AddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1311 MAMARONECK AVENUE | AddressLine1 |
| City | WHITE PLAINS | City |
| State | NY | State |
| ZIP Code | 10605 | ZIPCode |
Form990 Part VII Section A Form990PartVIISectionA (40 entries)
| TitleTitle | Average Hours Per WeekAverageHoursPerWeek | Individual Trustee Or DirectorIndividualTrusteeOrDirector | Reportable Comp From OrganizationReportableCompFromOrganization | Reportable Comp From Related OrgsReportableCompFromRelatedOrgs | Other CompensationOtherCompensation | OfficerOfficer | Highest Compensated EmployeeHighestCompensatedEmployee |
|---|---|---|---|---|---|---|---|
| STEVEN HOOKER | |||||||
| CHAIR OF THE | 1.00 | X | 0 | 0 | 0 | ||
| SCOTT CARROLL | |||||||
| VICE CHAIR | 1.00 | X | 0 | 0 | 0 | ||
| KEVIN RYAN | |||||||
| SECRETARY/TR | 1.00 | X | 0 | 0 | 0 | ||
| DAVID FRANTZE | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| TIMOTHY DURST | |||||||
| AT-LARGE | 1.00 | X | 0 | 0 | 0 | ||
| JAMES BECK | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| ALEXANDRA MAYES BIRNBAUM | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| ROBERT CANTLEY | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| ELIZABETH CLARK | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| JORGE CORTES MD | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| JAMES DAVIS PHD JD | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| CLAUDE DAVIS | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| THOMAS FITZPATRICK | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| PAUL FRIMMER | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| ALAN GEWIRTZ MD | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| D GARY GILLILAND MD PHD | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| RAANAN HOROWITZ | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| THOMAS HUNTER | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| JOHN KAMINS | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| ARMAND KEATING MD | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| JOESEPH KELLEY | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| MARIE LAURIA MSW | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| STEVEN LILLY | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| MICHAEL LONG PHD | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| RODMAN MYERS | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| NORBERT SIEBER | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| JAY SILVER | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| MARY SIMMONDS MD | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| THOMAS SNYDER | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| WILLIAM WARD JR | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| LOUISE WARNER | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| KATHRYN WEST | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| MICHELE WONG | |||||||
| BOD MEMBER | 1.00 | X | 0 | 0 | 0 | ||
| JOHN WALTER | |||||||
| PRESIDENT & | 35.00 | 518499 | 0 | 50111 | X | ||
| JAMES T NANGLE | |||||||
| SVP & CFO | 35.00 | 248021 | 0 | 41909 | X | ||
| LOUIS DEGENNERO PHD | |||||||
| EVP, CHIEF M | 35.00 | 316449 | 0 | 30613 | X | ||
| NANCY KLEIN | |||||||
| CHIEF MKTG & | 35.00 | 306528 | 0 | 43379 | X | ||
| BARTON KAMEN MD | |||||||
| CHIEF MEDICA | 35.00 | 280933 | 0 | 36057 | X | ||
| DAVID TIMKO | |||||||
| SVP CHAPTER | 35.00 | 247014 | 0 | 36211 | X | ||
| JANE KARLIN | |||||||
| VP MISSION A | 35.00 | 236754 | 0 | 29750 | X | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | 2154198 | TotalReportableCompFromOrg |
| Total Other Compensation | 268030 | TotalOtherCompensation |
| Number Individuals GT100 K | 81 | NumberIndividualsGT100K |
| Formers Listed | false | FormersListed |
| Total Comp GT150 K | true | TotalCompGT150K |
| Compensation From Other Sources | false | CompensationFromOtherSources |
Contractor Compensation ContractorCompensation (5 entries)
| Address Line1AddressOfContractor/AddressUS/AddressLine1 | Address Line2AddressOfContractor/AddressUS/AddressLine2 | CityAddressOfContractor/AddressUS/City | StateAddressOfContractor/AddressUS/State | ZIP CodeAddressOfContractor/AddressUS/ZIPCode | Description Of ServicesDescriptionOfServices | CompensationCompensation |
|---|---|---|---|---|---|---|
| PARADYSZ MATERA | ||||||
| 5 HANOVER SQUARE | 6TH FLOOR | NEW YORK | NY | 10004 | SUPPORTING SERV | 3985110 |
| DIRECT PRINT COMMUNICATIONS | ||||||
| 201 EAST SANDPIPE | SUITE 400 | SANTA ANA | CA | 92707 | SUPPORTING SERV | 2765429 |
| MSP | ||||||
| PO BOX 641114 | PITTSBURGH | PA | 15264 | SUPPORTING SERV | 2733597 | |
| INFOCISION MANAGEMENT CORPORATION | ||||||
| 325 SPRINGSIDE DRIVE | AKRON | OH | 44333 | SUPPORTING SERV | 2454336 | |
| ROBERT MICHAEL EDUCATIONAL INSTITUT | ||||||
| 617 STATION AVENUE | HADDON HEIGHTS | NJ | 08035 | SUPPORT SERVICE | 2150849 | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Number Of Contractors GT100 K | 49 | NumberOfContractorsGT100K |
| Federated Campaigns | 2635020 | FederatedCampaigns |
| Fundraising Events | 150595888 | FundraisingEvents |
| Government Grants | 501561 | GovernmentGrants |
| All Other Contributions | 84543942 | AllOtherContributions |
| Noncash Contributions | 412179 | NoncashContributions |
| Total Contributions | 238276411 | TotalContributions |
Investment Income InvestmentIncome
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 4954148 | TotalRevenueColumn |
| Exclusion | $4,954,148 | ExclusionAmount |
Royalties Revenue RoyaltiesRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 8491 | TotalRevenueColumn |
| Exclusion | $8,491 | ExclusionAmount |
Gross Amount Sales Assets GrossAmountSalesAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 115421136 | Securities |
Less Cost Oth Basis Sales Expenses LessCostOthBasisSalesExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 114430095 | Securities |
Gain Or Loss GainOrLoss
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | 991041 | Securities |
Net Gain Or Loss Investments NetGainOrLossInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 991041 | TotalRevenueColumn |
| Unrelated Business Revenue | -6739 | UnrelatedBusinessRevenue |
| Exclusion | $997,780 | ExclusionAmount |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Income Fundraising Events | 34842414 | GrossIncomeFundraisingEvents |
| Cntrbtns Rprtd Fundraising Events | 150595888 | CntrbtnsRprtdFundraisingEvents |
| Fundraising Direct Expenses | 34842414 | FundraisingDirectExpenses |
| Gross Income Gaming | 826998 | GrossIncomeGaming |
| Gaming Direct Expenses | 238877 | GamingDirectExpenses |
Net Income From Gaming NetIncomeFromGaming
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 588121 | TotalRevenueColumn |
| Related Or Exempt Function Income | 588121 | RelatedOrExemptFunctionIncome |
Other Revenue Misc OtherRevenueMisc (2 entries)
| DescriptionDescription | Business CodeBusinessCode | Total Revenue ColumnTotalRevenueColumn | ExclusionExclusionAmount |
|---|---|---|---|
| GRANT TERMINATIONS | 541900 | 1897430 | $1,897,430 |
| OTHER MISCELLANEOUS | 900099 | 28404 | $28,404 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Revenue | 1925834 | TotalOtherRevenue |
Total Revenue TotalRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | 246744046 | TotalRevenueColumn |
| Related Or Exempt Function Income | 588121 | RelatedOrExemptFunctionIncome |
| Unrelated Business Revenue | -6739 | UnrelatedBusinessRevenue |
| Exclusion | $7,886,253 | ExclusionAmount |
Grants To Domestic Orgs GrantsToDomesticOrgs
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 59486805 | Total |
| Program Services | 59486805 | ProgramServices |
Grants To Domestic Individuals GrantsToDomesticIndividuals
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 20061991 | Total |
| Program Services | 20061991 | ProgramServices |
Foreign Grants ForeignGrants
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 6029071 | Total |
| Program Services | 6029071 | ProgramServices |
Comp Current Officers Directors CompCurrentOfficersDirectors
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 842097 | Total |
| Program Services | 629920 | ProgramServices |
| Management And General | 96135 | ManagementAndGeneral |
| Fundraising | 116042 | Fundraising |
Other Salaries And Wages OtherSalariesAndWages
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 61996074 | Total |
| Program Services | 46375317 | ProgramServices |
| Management And General | 7077546 | ManagementAndGeneral |
| Fundraising | 8543211 | Fundraising |
Pension Plan Contributions PensionPlanContributions
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 4085026 | Total |
| Program Services | 2944324 | ProgramServices |
| Management And General | 451095 | ManagementAndGeneral |
| Fundraising | 689607 | Fundraising |
Other Employee Benefits OtherEmployeeBenefits
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 10397524 | Total |
| Program Services | 7494122 | ProgramServices |
| Management And General | 1148163 | ManagementAndGeneral |
| Fundraising | 1755239 | Fundraising |
Payroll Taxes PayrollTaxes
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 4514182 | Total |
| Program Services | 3253642 | ProgramServices |
| Management And General | 498486 | ManagementAndGeneral |
| Fundraising | 762054 | Fundraising |
Fees For Services Legal FeesForServicesLegal
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 547944 | Total |
| Program Services | 287986 | ProgramServices |
| Management And General | 88829 | ManagementAndGeneral |
| Fundraising | 171129 | Fundraising |
Fees For Services Accounting FeesForServicesAccounting
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 290180 | Total |
| Program Services | 152511 | ProgramServices |
| Management And General | 47042 | ManagementAndGeneral |
| Fundraising | 90627 | Fundraising |
Fees For Services Lobbying FeesForServicesLobbying
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 69750 | Total |
| Program Services | 36657 | ProgramServices |
| Management And General | 11307 | ManagementAndGeneral |
| Fundraising | 21786 | Fundraising |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 9299646 | Total |
| Fundraising | 9299646 | Fundraising |
Fees For Services Invst Mgmnt Fees FeesForServicesInvstMgmntFees
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 558368 | Total |
| Program Services | 293465 | ProgramServices |
| Management And General | 90518 | ManagementAndGeneral |
| Fundraising | 174385 | Fundraising |
Fees For Services Other FeesForServicesOther
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 11733772 | Total |
| Program Services | 6166971 | ProgramServices |
| Management And General | 1902211 | ManagementAndGeneral |
| Fundraising | 3664590 | Fundraising |
Advertising Advertising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 4105785 | Total |
| Program Services | 1728464 | ProgramServices |
| Management And General | 751479 | ManagementAndGeneral |
| Fundraising | 1625842 | Fundraising |
Office Expenses OfficeExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 33285307 | Total |
| Program Services | 14564003 | ProgramServices |
| Management And General | 5421889 | ManagementAndGeneral |
| Fundraising | 13299415 | Fundraising |
Information Technology InformationTechnology
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 3296375 | Total |
| Program Services | 1732491 | ProgramServices |
| Management And General | 534389 | ManagementAndGeneral |
| Fundraising | 1029495 | Fundraising |
Occupancy Occupancy
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 8324067 | Total |
| Program Services | 6010970 | ProgramServices |
| Management And General | 989754 | ManagementAndGeneral |
| Fundraising | 1323343 | Fundraising |
Travel Travel
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 1907526 | Total |
| Program Services | 1407448 | ProgramServices |
| Management And General | 222128 | ManagementAndGeneral |
| Fundraising | 277950 | Fundraising |
Conferences Meetings ConferencesMeetings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 4405367 | Total |
| Program Services | 3698619 | ProgramServices |
| Management And General | 316358 | ManagementAndGeneral |
| Fundraising | 390390 | Fundraising |
Depreciation Depletion DepreciationDepletion
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 1763665 | Total |
| Program Services | 1240461 | ProgramServices |
| Management And General | 178086 | ManagementAndGeneral |
| Fundraising | 345118 | Fundraising |
Insurance Insurance
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 527705 | Total |
| Program Services | 369622 | ProgramServices |
| Management And General | 51724 | ManagementAndGeneral |
| Fundraising | 106359 | Fundraising |
Other Expenses OtherExpenses (2 entries)
| DescriptionDescription | TotalTotal | Program ServicesProgramServices | Management And GeneralManagementAndGeneral | FundraisingFundraising |
|---|---|---|---|---|
| MISCELLANEOUS | 2679419 | 1948443 | 320546 | 410430 |
| DUES & SUBSCRIPTIONS | 274695 | 115642 | 50277 | 108776 |
Total Functional Expenses TotalFunctionalExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 250482341 | Total |
| Program Services | 186028945 | ProgramServices |
| Management And General | 20247962 | ManagementAndGeneral |
| Fundraising | 44205434 | Fundraising |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Joint Costs | X | JointCosts |
Total Joint Costs TotalJointCosts
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | 21448925 | Total |
| Program Services | 10527255 | ProgramServices |
| Fundraising | 10921670 | Fundraising |
Savings And Temp Cash Investments SavingsAndTempCashInvestments
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 26580133 | BOY |
| EOY | 19677285 | EOY |
Pledges And Grants Receivable PledgesAndGrantsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 21462843 | BOY |
| EOY | 16815436 | EOY |
Accounts Receivable AccountsReceivable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 401467 | BOY |
| EOY | 199138 | EOY |
Prepaid Expenses Deferred Charges PrepaidExpensesDeferredCharges
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 4110133 | BOY |
| EOY | 4262608 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Buildings Equipment Basis | 12858777 | LandBuildingsEquipmentBasis |
| Land Bldg Equipment Accum Deprec | 7852339 | LandBldgEquipmentAccumDeprec |
Land Buildings Equipment Basis Net LandBuildingsEquipmentBasisNet
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 4494218 | BOY |
| EOY | 5006438 | EOY |
Investments Pub Traded Securities InvestmentsPubTradedSecurities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 141373506 | BOY |
| EOY | 128755483 | EOY |
Investments Other Securities InvestmentsOtherSecurities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 18681828 | BOY |
| EOY | 46943952 | EOY |
Total Assets TotalAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 217104128 | BOY |
| EOY | 221660340 | EOY |
Accounts Payable Accrued Expenses AccountsPayableAccruedExpenses
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 14237670 | BOY |
| EOY | 15911173 | EOY |
Grants Payable GrantsPayable
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 85117561 | BOY |
| EOY | 79972494 | EOY |
Deferred Revenue DeferredRevenue
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 14886577 | BOY |
| EOY | 16329604 | EOY |
Total Liabilities TotalLiabilities
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 114241808 | BOY |
| EOY | 112213271 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Follow SFAS117 | X | FollowSFAS117 |
Unrestricted Net Assets UnrestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 77352419 | BOY |
| EOY | 87166990 | EOY |
Temporarily Restricted Net Assets TemporarilyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 22815500 | BOY |
| EOY | 19507519 | EOY |
Permanently Restricted Net Assets PermanentlyRestrictedNetAssets
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 2694401 | BOY |
| EOY | 2772560 | EOY |
Total Net Assets Fund Balances TotalNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 102862320 | BOY |
| EOY | 109447069 | EOY |
Total Liab Net Assets Fund Balances TotalLiabNetAssetsFundBalances
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | 217104128 | BOY |
| EOY | 221660340 | EOY |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Method Of Accounting Accrual | X | MethodOfAccountingAccrual |
| Accountant Compile Or Review | false | AccountantCompileOrReview |
| FS Audited | true | FSAudited |
| Audit Committee | true | AuditCommittee |
| Financial Statement Separate | X | FinancialStatementSeparate |
| Federal Grant Audit Required | false | FederalGrantAuditRequired |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Publicly Supported Org170b1 Avi | X | PubliclySupportedOrg170b1Avi |
Gifts Grants Contrib Received170 GiftsGrantsContribReceived170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 223588366 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 246772831 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 256914242 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 269310797 | CurrentTaxYearMinus1Year |
| Current Tax Year | 238864532 | CurrentTaxYear |
| Total | 1235450768 | Total |
Total170 Total170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 223588366 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 246772831 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 256914242 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 269310797 | CurrentTaxYearMinus1Year |
| Current Tax Year | 238864532 | CurrentTaxYear |
| Total | 1235450768 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Support Total170 | 1235450768 | PublicSupportTotal170 |
Gross Investment Income170 GrossInvestmentIncome170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 4459726 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 6538216 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 7451748 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 6950554 | CurrentTaxYearMinus1Year |
| Current Tax Year | 4962639 | CurrentTaxYear |
| Total | 30362883 | Total |
Other Income170 OtherIncome170
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | 1773903 | CurrentTaxYearMinus4Years |
| Current Tax Year Minus3 Years | 1446752 | CurrentTaxYearMinus3Years |
| Current Tax Year Minus2 Years | 1098580 | CurrentTaxYearMinus2Years |
| Current Tax Year Minus1 Year | 2816918 | CurrentTaxYearMinus1Year |
| Current Tax Year | 1925834 | CurrentTaxYear |
| Total | 9061987 | Total |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | 1274875638 | TotalSupport |
| Gross Receipts From Admissions Etc | 193744070 | GrossReceiptsFromAdmissionsEtc |
| Public Support Pertcentage170 | 0.96910 | PublicSupportPertcentage170 |
| Public Support Pertcent Prior Year | 0.97070 | PublicSupportPertcentPriorYear |
| Thirty Three Percnt Tests CY170 | X | ThirtyThreePercntTestsCY170 |
Schedule B IRS990ScheduleB
Contributor Info ContributorInfo
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contributor Number | RESTRICTED | ContributorNumber |
Contributor Name Business ContributorNameBusiness
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | RESTRICTED | BusinessNameLine1 |
Contributor Address US ContributorAddressUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | RESTRICTED | AddressLine1 |
| Address Line2 | RESTRICTED | AddressLine2 |
| City | RESTRICTED | City |
| State | RESTRICTED | State |
| ZIP Code | RESTRICTED | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Aggregate Contributions | RESTRICTED | AggregateContributions |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form4720 Filed4955 Tax | false | Form4720Filed4955Tax |
| Correction Made | false | CorrectionMade |
| Form1120 Pol Filed | false | Form1120PolFiled |
| Form4720 Filed | false | Form4720Filed |
| Volunteers | true | Volunteers |
| Paid Staff Or Management | true | PaidStaffOrManagement |
| Media Advertisements | false | MediaAdvertisements |
| Mailings Members | true | MailingsMembers |
| Mailings Members | $30,000 | MailingsMembersAmount |
| Publications Or Broadcast | true | PublicationsOrBroadcast |
| Publications Or Broadcast | $8,000 | PublicationsOrBroadcastAmount |
| Grants Other Organizations | false | GrantsOtherOrganizations |
| Direct Contact Legislators | true | DirectContactLegislators |
| Rallies Demonstrations | true | RalliesDemonstrations |
| Rallies Demonstrations | $15,000 | RalliesDemonstrationsAmount |
| Other Activities | true | OtherActivities |
| Other Activities | $16,750 | OtherActivitiesAmount |
| Total Lobbying Expenditures IIB | 69750 | TotalLobbyingExpendituresIIB |
| Not Described In501c3 | false | NotDescribedIn501c3 |
| Form4720 Filed4912 Tax | false | Form4720Filed4912Tax |
| Substantially All Dues Nondeduct | false | SubstantiallyAllDuesNondeduct |
| Only In House Lobbying | false | OnlyInHouseLobbying |
| Agree To Carryover Prior Year | false | AgreeToCarryoverPriorYear |
Form990 Schedule C Part IV Form990ScheduleCPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Reference | SCHEDULE C, PART II-B, LINE 1I | ReturnReference |
| Explanation | LLS IS A MEMBER OF A NUMBER OF COALITIONS INCLUDING RESEARCH AMERICA, ONE VOICE AGAINST CANCER, NATIONAL COALITION FOR CANCER RESEARCH,COALITION FOR THE ADVANCEMENT OF MEDICAL RESEARCH, AND ALLIANCE FOR A STRONGER FDA. | Explanation |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Disclosed Orgs Legal Control | false | DisclosedOrgsLegalControl |
| Disclosed For Charitable Purposes | false | DisclosedForCharitablePurposes |
| Written Policy Monitoring | false | WrittenPolicyMonitoring |
| Sect170h Requirements Satisfied | false | Sect170hRequirementsSatisfied |
| Collect Used For Public Exhibition | X | CollectUsedForPublicExhibition |
| Solicited Assets For Sale | false | SolicitedAssetsForSale |
| Agent Trustee Etc | false | AgentTrusteeEtc |
| Included On FS | false | IncludedOnFS |
Current Year CurrentYear
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 4481610 | BeginningOfYearBalance |
| Investment Earnings Or Losses | 563236 | InvestmentEarningsOrLosses |
| Administrative Expenses | -20944 | AdministrativeExpenses |
| End Of Year Balance | 5023902 | EndOfYearBalance |
Current Year Minus1 Year CurrentYearMinus1Year
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Of Year Balance | 5228375 | BeginningOfYearBalance |
| Investment Earnings Or Losses | -730333 | InvestmentEarningsOrLosses |
| Administrative Expenses | -16432 | AdministrativeExpenses |
| End Of Year Balance | 4481610 | EndOfYearBalance |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Permanent Endowment EOY Balance | 0.55000 | PermanentEndowmentEOYBalance |
| Term Endowment EOY Balance | 0.45000 | TermEndowmentEOYBalance |
| Endowments Held By Unrelated Orgs | false | EndowmentsHeldByUnrelatedOrgs |
| Endowments Held By Related Orgs | false | EndowmentsHeldByRelatedOrgs |
| Are Related Orgs Listed Schedule R | false | AreRelatedOrgsListedScheduleR |
Leasehold Improvements LeaseholdImprovements
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 1224014 | OtherCostOrOtherBasis |
| Depreciation | 1063522 | Depreciation |
| Book Value | 160492 | BookValue |
Equipment Equipment
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 6649622 | OtherCostOrOtherBasis |
| Depreciation | 4103453 | Depreciation |
| Book Value | 2546169 | BookValue |
Other Land Buildings OtherLandBuildings
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | 4985141 | OtherCostOrOtherBasis |
| Depreciation | 2685364 | Depreciation |
| Book Value | 2299777 | BookValue |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Book Value Land Buildings | 5006438 | TotalOfBookValueLandBuildings |
Other Securities OtherSecurities (10 entries)
| DescriptionDescription | Book ValueBookValue | Method Of ValuationMethodOfValuation |
|---|---|---|
| PACIFIC HEDGED STRATEGIES | 17038500 | F |
| GROSVENOR FUND | 16899115 | F |
| RAFI OPERATING | 6369633 | F |
| RAFI INTERNATIONAL | 4326037 | F |
| PRINCIPAL 457B | 545572 | F |
| PACIFIC HEDGED ENDOWMENT | 503076 | F |
| GROSVENOR ENDOWMENT | 502470 | F |
| RAFI INTERNATIONAL ENDOWMENT | 450000 | F |
| RAFI POOLED ENDOWMENT | 306345 | F |
| OTHER | 3204 | F |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Of Book Value Securities | 46943952 | TotalOfBookValueSecurities |
| Total Revenue | 246744046 | TotalRevenue |
| Total Expenses | 250482341 | TotalExpenses |
| Excess Or Deficit For Year | -3738295 | ExcessOrDeficitForYear |
| Net Unrealized GL On Investments | 10322289 | NetUnrealizedGLOnInvestments |
| Other | $742,006 | OtherAmount |
| Total Adjustments | 11064295 | TotalAdjustments |
| Excess Or Deficit Per FS | 7326000 | ExcessOrDeficitPerFS |
| Tot Revenue Etc Audited Fincl Stmt | 274808000 | TotRevenueEtcAuditedFinclStmt |
| Net Unrealized Gains Investments | 10322289 | NetUnrealizedGainsInvestments |
| Donated Srvc And Use Of Facilities | 6819125 | DonatedSrvcAndUseOfFacilities |
| Other Revenues | 11480908 | OtherRevenues |
| Revenue Not Rptd F990 | 28622322 | RevenueNotRptdF990 |
| Revenue Subtotal | 246185678 | RevenueSubtotal |
| Investment Expenses Not Included | 558368 | InvestmentExpensesNotIncluded |
| Revenue Not Rptd On Fin Stmt | 558368 | RevenueNotRptdOnFinStmt |
| Total Revenue Per Form990 | 246744046 | TotalRevenuePerForm990 |
| Tot Expenses Etc Audited Fincl Stmt | 267703000 | TotExpensesEtcAuditedFinclStmt |
| Donated Services Use Of Facilities | 6819125 | DonatedServicesUseOfFacilities |
| Other Expenses Included | 10959902 | OtherExpensesIncluded |
| Expenses Not Rptd F990 | 17779027 | ExpensesNotRptdF990 |
| Expenses Subtotal | 249923973 | ExpensesSubtotal |
| Investment Expenses Not Included2 | 558368 | InvestmentExpensesNotIncluded2 |
| Expenses Not Rptd On Fin Stmt | 558368 | ExpensesNotRptdOnFinStmt |
| Total Expenses Per Form990 | 250482341 | TotalExpensesPerForm990 |
Form990 Schedule D Part XIV Form990ScheduleDPartXIV (6 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| COLLECTIONS AND RELATION TO EXEMPT PURPOSE | SCHEDULE D, PAGE 2, PART III, LINE 4 | THE LLS'S COLLECTION IS OF PHOTOGRAPHS WHICH ARE USED FOR PUBLIC EXHIBITION AT FUNDRAISING EVENTS HELD TO SUPPORT LLS'S PROGRAMS. |
| INTENDED USES FOR ENDOWMENT FUNDS | SCHEDULE D, PAGE 2, PART V, LINE 4 | LLS'S ENDOWMENTS ARE INTENDED TO FUND RESEARCH AS WELL AS SUPPORT LLS'S PUBLIC EDUCATION PROGRAMS. |
| RECONCILATION OF CHANGES - OTHER | SCHEDULE D, PAGE 4, PART XI, LINE 8 | LSRP REVENUE 34,484 LLS CANADA REVENUE 11,446,309 ROUNDING FOR AUDITED FINANCIAL STATEMENTS 115 LLS CANADA EXPENSE -10,964,445 ROUNDING FOR AUDITED FINANCIAL STATEMENTS 4,543 |
| REVENUE AMOUNTS INCLUDED IN FINANCIALS - OTHER | SCHEDULE D, PAGE 4, PART XII, LINE 2D | LSRP REVENUE 34,484 LLS CANADA REVENUE 11,446,309 ROUNDING FOR AUDITED FINANCIAL STATEMENTS 115 |
| EXPENSE AMOUNTS INCLUDED IN FINANCIALS - OTHER | SCHEDULE D, PAGE 4, PART XIII, LINE 2D | LLS CANADA EXPENSE 10,964,445 ROUNDING FOR AUDITED FINANCIAL STATEMENTS -4,543 |
| SUPPLEMENTAL FINANCIAL INFORMATION | SCHEDULE D, PAGE 4, PART XIV | PART III, LINE 1A: THE LEUKEMIA & LYMPHOMA SOCIETY MAINTAINS A SMALL PHOTOGRAPH COLLECTION FOR PUBLIC EXHIBITION WHICH HAS AN ESTIMATED VALUE BETWEEN 20,000 AND 50,000. AS THIS REPRESENTS A RELATIVELY SMALL PERCENTAGE OF LLS'S ASSETS, IT IS NOT SEPARATELY DISCLOSED IN THE FINANCIAL STATEMENTS OR FOOTNOTES. PART X, LINE 2: IN 2010, LLS ADOPTED ASC 740, ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. LLS EVALUATED THE IMPACT OF ADOPTING THE ACCOUNTING AND DISCLOSURE REQUIREMENTS OF ASC 740 FOR UNCERTAINTIES IN INCOME TAXES RECOGNIZED IN THE CONSOLIDATED FINANCIAL STATEMENTS, WHICH PRESCRIBES A THRESHOLD OF MORE-LIKELY-THAN-NOT FOR RECOGNITION AND DE-RECOGNITION OF TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. THERE WAS NO SIGNIFICANT IMPACT TO LLS'S CONSOLIDATED FINANCIAL STATEMENTS AS A RESULT OF THE ADOPTION OF ASC740. PART XI, LINE 8: RECONCILIATION OF CHANGE IN NET ASSETS ON A CONSOLIDATED BASIS TO SEPARATE COMPANY BASIS: CHANGE IN NET ASSETS PER AUDITED FINANCIAL STATEMENTS 7,326,000 PLUS: CHANGE IN NET ASSETS LLS CANADA (481,864) PLUS: LLSRF AND LLSRP ACTIVITY (33,729) PLUS: FOREIGN CURRENCY TRANSLATION ADJUSTMENT (221,000) PLUS: AUDITED FINANCIAL STATEMENT ROUNDING (4,658) EQUALS: CHANGE IN NET ASSETS PER 990 6,584,749 THE AUDITED FINANCIAL STATEMENTS FOR THE LEUKEMIA & LYMPHOMA SOCIETY, INC. INCLUDE THE LEUKEMIA & LYMPHOMA SOCIETY OF CANADA, THE LEUKEMIA & LYMPHOMA SOCIETY RESEARCH PROGRAMS, INC., AND THE LEUKEMIA & LYMPHOMA SOCIETY RESEARCH FOUNDATION IN ADDITION TO LLS. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | true | GrantRecordsMaintained |
Accts Actvs Out US Table AcctsActvsOutUSTable (4 entries)
| RegionRegion | Number Of OfficesNumberOfOffices | Number Of EmployeesNumberOfEmployees | Type Of Activities ConductedTypeOfActivitiesConducted | Specific Services ProvidedSpecificServicesProvided | Total ExpendituresTotalExpenditures |
|---|---|---|---|---|---|
| EAST ASIA | 6 | 6 | RESEARCH FUNDING | RESEARCH GRANTS | 2005000 |
| NORTH AMERICA | 12 | 12 | RESEARCH FUNDING | RESEARCH GRANTS | 1635071 |
| EUROPE | 9 | 9 | RESEARCH FUNDING | RESEARCH GRANTS | 2189000 |
| MIDDLE EAST | 1 | 1 | RESEARCH FUNDING | RESEARCH GRANTS | 200000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Number Of Offices | 28 | TotalNumberOfOffices |
| Total Number Of Employees | 28 | TotalNumberOfEmployees |
| Total Amount Spent | 6029071 | TotalAmountSpent |
Grants To Orgs Outside US GrantsToOrgsOutsideUS (28 entries)
| RegionRegion | Purpose Of GrantPurposeOfGrant | Amount Of Cash GrantAmountOfCashGrant | Manner Of Cash DisbursementMannerOfCashDisbursement |
|---|---|---|---|
| EAST ASIA & PACIFIC | RESEARCH GRANT | 1250000 | CHECK |
| EAST ASIA & PACIFIC | RESEARCH GRANT | 55000 | CHECK |
| EAST ASIA & PACIFIC | RESEARCH GRANT | 200000 | CHECK |
| EAST ASIA & PACIFIC | RESEARCH GRANT | 200000 | CHECK |
| EAST ASIA & PACIFIC | RESEARCH GRANT | 200000 | CHECK |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK |
| NORTH AMERICA | RESEARCH GRANT | 55000 | CHECK |
| NORTH AMERICA | RESEARCH GRANT | 65000 | CHECK |
| NORTH AMERICA | RESEARCH GRANT | 110000 | CHECK |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK |
| NORTH AMERICA | RESEARCH GRANT | 200000 | CHECK |
| NORTH AMERICA | RESEARCH GRANT | 65000 | CHECK |
| EUROPE | RESEARCH GRANT | 55000 | CHECK |
| MIDDLE EAST AND NORTH AFRICA | RESEACH GRANT | 200000 | CHECK |
| EUROPE | RESEARCH GRANT | 200000 | CHECK |
| EUROPE | RESEARCH GRANT | 65000 | CHECK |
| EAST ASIA & PACIFIC | RESEARCH GRANT | 100000 | CHECK |
| EUROPE | RESEARCH GRANT | 200000 | CHECK |
| EUROPE | RESEARCH GRANT | 54000 | CHECK |
| EUROPE | RESEARCH GRANT | 1250000 | CHECK |
| EUROPE | RESEARCH GRANT | 110000 | CHECK |
| EUROPE | RESEARCH GRANT | 200000 | CHECK |
| EUROPE | RESEARCH GRANT | 55000 | CHECK |
| NORTH AMERICA | THERAPY ACCELERATION | 307026 | CHECK |
| NORTH AMERICA | THERAPY ACCELERATION | 26159 | CHECK |
| NORTH AMERICA | THERAPY ACCELERATION | 6886 | CHECK |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Number Of Other Orgs | 28 | TotalNumberOfOtherOrgs |
Form990 Schedule F Part IV Form990ScheduleFPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS OUTSIDE THE UNITED STATES | Identifier |
| Return Reference | SCHEDULE F, PAGE 1, PART I, LINE 2 | ReturnReference |
| Explanation | FIDUCIARY RESPONSIBILITY AND TRANSPARENCY TO OUR DONORS IS A HIGH PRIORITY. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) PLACES CONSIDERABLE EMPHASIS ON THE OVERSIGHT OF GRANT SPENDING. TO ACCOMPLISH THIS OBEJECTIVE WE REQUIRE THE SUBMISSION OF ANNUAL FINANCIAL REPORTS FOR EACH OF OUR ACTIVE GRANTS. THE REPORT MUST BE SIGNED BY THE FINANCIAL OFFICER AND/OR THE DESIGNATED OFFICIAL OF THE INSTITUTION HOSTING THE AWARD. AT THE END OF THE GRANT, WE REQUIRE A FINAL FINANCIAL REPORT THAT PROVIDES AN OVERVIEW OF ALL SPENDING THROUGH THE DURATION OF THE AWARD. WE REQUIRE SPECIFIC ACCOUNTING OF SPENDING ON PERSONNEL, CONSULTANTS, EQUIPMENT PURCHASES, SUPPLIES, TRAVEL, PATIENT CARE COSTS, ANIMAL CARE COSTS, AND ANY OTHER EXPENSE A GRANTEE MAY INCUR. WE HAVE SPECIFIC INSTRUCTIONS AND DOLLAR AMOUNT LIMITATIONS SET FOR MANY OF THESE CATEGORIES DEPENDING ON THE AWARD TYPE. FINANCIAL REPORTS ARE REVIEWED FOR NUMERICAL ACCURACY, ADHERENCE TO OUR GUIDELINES, AND FOR THE VERIFICATION OF APPROVAL FROM THE INSTITUTION'S FINANCIAL OFFICER. IF THE GRANTEE DOES NOT SUBMIT AN ANNUAL FINANCIAL REPORT BY THE DUE DATE OUTLINED IN THEIR CONTRACT, FUNDING IS SUSPENDED UNTIL LLS RECEIVES AND APPROVES THE DELINQUENT REPORT. | Explanation |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| Mail Solicitations | X | MailSolicitations |
| Email Solicitations | X | EmailSolicitations |
| Phone Solicitations | X | PhoneSolicitations |
| In Person Solicitations | X | InPersonSolicitations |
| Solicitation Of Non Govt Grants | X | SolicitationOfNonGovtGrants |
| Solicitation Of Govt Grants | X | SolicitationOfGovtGrants |
| Special Fundraising Events | X | SpecialFundraisingEvents |
| Agreement Ref Fundraising | true | AgreementRefFundraising |
Fundraiser Activity Information FundraiserActivityInformation (6 entries)
| Name Of IndividualNameOfIndividual | ActivityActivity | Fundraiser Control Of FundsFundraiserControlOfFunds | Amount Retained By ContractorAmountRetainedByContractor | Net To OrganizationNetToOrganization |
|---|---|---|---|---|
| PARADYSZ MATERA | DIRECT MAI | false | 3985110 | -3985110 |
| DIRECT PRINT COMMUNICATIONS | DIRECT MAI | false | 2765429 | -2765429 |
| INFOCISION | TELEMARKET | false | 2454336 | -2454336 |
| THOMPSON HABIB DENISON | DIRECT MAI | false | 614771 | -614771 |
| PIDI | DIRECT MAI | false | 198149 | -198149 |
| HAINES COAMERICALIST | TELEMARKET | false | 145114 | -145114 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Retained By Contractors | 10162909 | TotalRetainedByContractors |
| All States | All States | AllStates |
Events Information EventsInformation
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Of Event1 | NIKE WOMEN'S MA | NameOfEvent1 |
| Gross Receipts Event1 | 12995811 | GrossReceiptsEvent1 |
| Charitable Contributions Event1 | 10030184 | CharitableContributionsEvent1 |
| Gross Revenue Event1 | 2965627 | GrossRevenueEvent1 |
| Other Direct Expenses Event1 | 2965627 | OtherDirectExpensesEvent1 |
| Name Of Event2 | ROCK N ROLL MAR | NameOfEvent2 |
| Gross Receipts Event2 | 11929170 | GrossReceiptsEvent2 |
| Charitable Contributions Event2 | 8552760 | CharitableContributionsEvent2 |
| Gross Revenue Event2 | 3376410 | GrossRevenueEvent2 |
| Other Direct Expenses Event2 | 3376410 | OtherDirectExpensesEvent2 |
| Total Number Of Other Events | 729 | TotalNumberOfOtherEvents |
| Gross Receipts Other Events | 160513321 | GrossReceiptsOtherEvents |
| Charitable Contrib Other Events | 132012944 | CharitableContribOtherEvents |
| Gross Revenue Other Events | 28500377 | GrossRevenueOtherEvents |
| Other Direct Expenses Other Events | 28500377 | OtherDirectExpensesOtherEvents |
| Gross Receipts Total | 185438302 | GrossReceiptsTotal |
| Charitable Contributions Total | 150595888 | CharitableContributionsTotal |
| Gross Revenue Total Events | 34842414 | GrossRevenueTotalEvents |
| Other Direct Expenses Total Events | 34842414 | OtherDirectExpensesTotalEvents |
| Direct Expense Summary Events | 34842414 | DirectExpenseSummaryEvents |
Gaming Information GamingInformation
| Field | Value | IRS element (for citing) |
|---|---|---|
| Volunteer Labor Bingo | false | VolunteerLaborBingo |
| Volunteer Labor Pull Tabs | false | VolunteerLaborPullTabs |
| Gross Revenue Other Gaming | 826998 | GrossRevenueOtherGaming |
| Cash Prizes Other Gaming | 24350 | CashPrizesOtherGaming |
| Non Cash Prizes Other Gaming | 211436 | NonCashPrizesOtherGaming |
| Other Direct Expenses Other Gaming | 3091 | OtherDirectExpensesOtherGaming |
| Volunteer Labor Other Gaming | true | VolunteerLaborOtherGaming |
| Volunteer Labor Prcnt Other Gaming | 0.12000 | VolunteerLaborPrcntOtherGaming |
| Gross Revenue Total Gaming | 826998 | GrossRevenueTotalGaming |
| Cash Prizes Total Gaming | 24350 | CashPrizesTotalGaming |
| Non Cash Prizes Total Gaming | 211436 | NonCashPrizesTotalGaming |
| Other Direct Expenses Total Gaming | 3091 | OtherDirectExpensesTotalGaming |
| Direct Expense Summary Gaming | 238877 | DirectExpenseSummaryGaming |
| Net Gaming Income Summary | 588121 | NetGamingIncomeSummary |
| Field | Value | IRS element (for citing) |
|---|---|---|
| States Where Gaming Conducted | CA | StatesWhereGamingConducted |
| States Where Gaming Conducted | CT | StatesWhereGamingConducted |
| States Where Gaming Conducted | FL | StatesWhereGamingConducted |
| States Where Gaming Conducted | LA | StatesWhereGamingConducted |
| States Where Gaming Conducted | MD | StatesWhereGamingConducted |
| States Where Gaming Conducted | MI | StatesWhereGamingConducted |
| States Where Gaming Conducted | MN | StatesWhereGamingConducted |
| States Where Gaming Conducted | NY | StatesWhereGamingConducted |
| States Where Gaming Conducted | OH | StatesWhereGamingConducted |
| States Where Gaming Conducted | PA | StatesWhereGamingConducted |
| States Where Gaming Conducted | RI | StatesWhereGamingConducted |
| States Where Gaming Conducted | TX | StatesWhereGamingConducted |
| States Where Gaming Conducted | WI | StatesWhereGamingConducted |
| States Where Gaming Conducted | AZ | StatesWhereGamingConducted |
| States Where Gaming Conducted | GA | StatesWhereGamingConducted |
| States Where Gaming Conducted | MA | StatesWhereGamingConducted |
| States Where Gaming Conducted | DC | StatesWhereGamingConducted |
| States Where Gaming Conducted | NJ | StatesWhereGamingConducted |
| States Where Gaming Conducted | NV | StatesWhereGamingConducted |
| States Where Gaming Conducted | VA | StatesWhereGamingConducted |
| States Where Gaming Conducted | WA | StatesWhereGamingConducted |
| Licensed | true | Licensed |
| License Suspended Etc | false | LicenseSuspendedEtc |
| Gaming With Nonmembers | false | GamingWithNonmembers |
| Member Of Other Entity | false | MemberOfOtherEntity |
| Percentage Of Gaming Own Facility | 0.02000 | PercentageOfGamingOwnFacility |
| Percentage Of Gaming Othr Facility | 0.98000 | PercentageOfGamingOthrFacility |
| Name Of Gaming Rec Keeper Person | JAMES T NANGLE CFO | NameOfGamingRecKeeperPerson |
Address Of Gaming Rec Keeper US AddressOfGamingRecKeeperUS
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1311 MAMARONECK AVENUE | AddressLine1 |
| City | WHITE PLAINS | City |
| State | NY | State |
| ZIP Code | 10605 | ZIPCode |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Contract With3rd Party For Gam Rev | false | ContractWith3rdPartyForGamRev |
| Charitable Distrib Required | false | CharitableDistribRequired |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Records Maintained | true | RecordsMaintained |
Recipient Table RecipientTable (309 entries)
| Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | EIN Of RecipientEINOfRecipient | IRC SectionIRCSection | Amount Of Cash GrantAmountOfCashGrant | Purpose Of GrantPurposeOfGrant |
|---|---|---|---|---|---|---|---|
| ALBERT EINSTEIN COLLEGE OF MEDICINE | |||||||
| CHANIN 302B 1300 MORRIS PARK AVE | BRONX | NY | 10461 | 131624225 | 3 | 200000 | RESEARCH GRANT |
| ALBERT EINSTEIN COLLEGE OF MEDICINE | |||||||
| CHANIN 302B 1300 MORRIS PARK AVE | BRONX | NY | 10461 | 131624225 | 3 | 200000 | RESEARCH GRANT |
| BAYLOR COLLEGE OF MEDICINE | |||||||
| 6621 FANNIN STREET MC3-3320 | HOUSTON | TX | 77030 | 741613878 | 3 | 110000 | RESEARCH GRANT |
| BAYLOR COLLEGE OF MEDICINE | |||||||
| GRANTS CONTRACTS ONE BAYLOR PLAZ | HOUSTON | TX | 770303498 | 741613878 | 3 | 200000 | RESEARCH GRANT |
| BAYLOR COLLEGE OF MEDICINE | |||||||
| GRANTS CONTRACTS ONE BAYLOR PLAZ | HOUSTON | TX | 770303498 | 741613878 | 3 | 65000 | RESEARCH GRANT |
| BAYLOR COLLEGE OF MEDICINE | |||||||
| 1102 BATES ST | HOUSTON | TX | 77030 | 741613878 | 3 | 1250000 | RESEARCH GRANT |
| BAYLOR COLLEGE OF MEDICINE | |||||||
| GRANTS CONTRACTS ONE BAYLOR PLAZ | HOUSTON | TX | 770303498 | 741613878 | 3 | 200000 | RESEARCH GRANT |
| BAYLOR COLLEGE OF MEDICINE | |||||||
| ROOM S303 ONE BAYLOR PLAZA | HOUSTON | TX | 77030 | 741613878 | 3 | 110000 | RESEARCH GRANT |
| BECKMAN RESEARCH INSTITUTE OF THE C | |||||||
| OFFICE OF SPONSORED RESEARCH 1450 E | DUARTE | CA | 910103000 | 953432210 | 3 | 200000 | RESEARCH GRANT |
| BETH ISRAEL DEACONESS MEDICAL CENTE | |||||||
| OFFICE OF RESEARCH FINANCE 330 BRO | BOSTON | MA | 02215 | 042103881 | 3 | 200000 | RESEARCH GRANT |
| BLOOD RESEARCH INSTITUTE BLOOD CE | |||||||
| 8727 W WATERTOWN PLANK ROAD | MILWAUKEE | WI | 53226 | 390807235 | 3 | 110000 | RESEARCH GRANT |
| BOSTON UNIVERSITY B U MEDICAL CAMP | |||||||
| 80 EAST CONCORD STREET ROOM K521 | BOSTON | MA | 02118 | 042103547 | 3 | 200000 | RESEARCH GRANT |
| BRANDEIS UNIVERSITY | |||||||
| 415 SOUTH STREET MS029 | WALTHAM | MA | 024549110 | 042103552 | 3 | 55000 | RESEARCH GRANT |
| BRANDEIS UNIVERSITY | |||||||
| 415 SOUTH STREET MS029 | WALTHAM | MA | 02454 | 042103552 | 3 | 55000 | RESEARCH GRANT |
| BRIGHAM & WOMENS HOSPITAL | |||||||
| 75 FRANCIS ST | BOSTON | MA | 02115 | 042312909 | 3 | 1250000 | RESEARCH GRANT |
| BRIGHAM & WOMEN'S HOSPITAL | |||||||
| RESEARCH MANAGEMENT POBOX 3149 | BOSTON | MA | 022413149 | 042312909 | 3 | 65000 | RESEARCH GRANT |
| BROWN UNIVERSITY | |||||||
| 171 MEETING PLACE BOX GB-6 581 B | PROVIDENCE | RI | 02912 | 050258809 | 3 | 110000 | RESEARCH GRANT |
| BURNHAM INSTITUTE FOR MEDICAL RESEA | |||||||
| 10901 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | 510197108 | 3 | 55000 | RESEARCH GRANT |
| CBR INSTITUTE OF BIOMEDICAL RESEARC | |||||||
| 200 LONGWOOD AVENUE | BOSTON | MA | 02115 | 530199180 | 3 | 1250000 | RESEARCH GRANT |
| CHILDRENS HOSPITAL OF PHILADELPHIA | |||||||
| 3615 CIVIC CENTER BOULEVARD | PHILADELPHIA | PA | 19104 | 231352166 | 3 | 1250000 | RESEARCH GRANT |
| CHILDRENS HOSPITAL OF PHILADELPHIA | |||||||
| 3615 CIVIC CENTER BOULEVARD | PHILADELPHIA | PA | 19104 | 231352166 | 3 | 110000 | RESEARCH GRANT |
| CHILDRENS HOSPITAL OF PHILADELPHIA | |||||||
| 3615 CIVIC CENTER BOULEVARD | PHILADELPHIA | PA | 191781457 | 231352166 | 3 | 110000 | RESEARCH GRANT |
| CHILDRENS HOSPITAL OF PHILADELPHIA | |||||||
| 3615 CIVIC CENTER BOULEVARD | PHILADELPHIA | PA | 19104 | 231352166 | 3 | 200000 | RESEARCH GRANT |
| CHILDREN'S HOSPITAL BOSTON | |||||||
| KARP 08211 300 LONGWOOD AVENUE | BOSTON | MA | 02115 | 042774441 | 3 | 110000 | RESEARCH GRANT |
| CHILDRENS HOSPITAL LOS ANGELES | |||||||
| 4650 SUNSET BLVD MAILSTOP 136 | LOS ANGELES | CA | 90027 | 951690977 | 3 | 200000 | RESEARCH GRANT |
| CHILDRENS HOSPITAL LOS ANGELES | |||||||
| 4650 SUNSET BLVD MAILSTOP 136 | LOS ANGELES | CA | 90027 | 951690977 | 3 | 200000 | RESEARCH GRANT |
| CHILDRENS HOSPITAL LOS ANGELES | |||||||
| 4650 SUNSET BLVD MAILSTOP 136 | LOS ANGELES | CA | 90027 | 951690977 | 3 | 200000 | RESEARCH GRANT |
| CHILDRENS HOSPITAL LOS ANGELES | |||||||
| 4650 SUNSET BLVD MAILSTOP 136 | LOS ANGELES | CA | 90027 | 951690977 | 3 | 110000 | RESEARCH GRANT |
| CHILDRENS HOSPITAL MEDICAL CENTER-C | |||||||
| 7013 3333 BURNET AVENUE | CINCINNATI | OH | 45229 | 310833936 | 3 | 110000 | RESEARCH GRANT |
| CHILDRENS HOSPITAL MEDICAL CENTER-C | |||||||
| 7013 3333 BURNET AVENUE | CINCINNATI | OH | 452293039 | 310833936 | 3 | 110000 | RESEARCH GRANT |
| CITY OF HOPE NATIONAL MEDICAL CENTE | |||||||
| ATTENTION GRANTS CONTRACTS MANAGE | DUARTE | CA | 910103000 | 953435919 | 3 | 200000 | RESEARCH GRANT |
| COLD SPRING HARBOR LABORATORY | |||||||
| 1 BUNGTOWN ROAD | COLD SPRING HARBOR | NY | 11724 | 111631792 | 3 | 1250000 | RESEARCH GRANT |
| COLUMBIA UNIVERSITY | |||||||
| 1150 ST NICHOLAS AVENUE | NEW YORK | NY | 10032 | 135598093 | 3 | 1250000 | RESEARCH GRANT |
| COLUMBIA UNIVERSITY | |||||||
| 1150 ST NICHOLAS AVENUE | NEW YORK | NY | 10032 | 135598093 | 3 | 110000 | RESEARCH GRANT |
| COLUMBIA UNIVERSITY | |||||||
| 1150 ST NICHOLAS AVENUE | NEW YORK | NY | 10032 | 135598093 | 3 | 110000 | RESEARCH GRANT |
| COLUMBIA UNIVERSITY | |||||||
| 1150 ST NICHOLAS AVENUE | NEW YORK | NY | 10032 | 135598093 | 3 | 110000 | RESEARCH GRANT |
| COLUMBIA UNIVERSITY | |||||||
| 1150 ST NICHOLAS AVENUE | NEW YORK | NY | 10032 | 135598093 | 3 | 200000 | RESEARCH GRANT |
| COLUMBIA UNIVERSITY | |||||||
| 1150 ST NICHOLAS AVENUE | NEW YORK | NY | 10032 | 135598093 | 3 | 65000 | RESEARCH GRANT |
| COLUMBIA UNIVERSITY | |||||||
| ICRC 1130 ST NICHOLAS AVEICRC 9TH | NEW YORK | NY | 10032 | 135598093 | 3 | 200000 | RESEARCH GRANT |
| CORNELL UNIVERSITY MEDICAL COLLEGE | |||||||
| RESEARCH/SPONSORED PRGMS 1300 YORK | NEW YORK | NY | 10021 | 133376695 | 3 | 200000 | RESEARCH GRANT |
| CORNELL UNIVERSITY MEDICAL COLLEGE | |||||||
| RESEARCH/SPONSORED PRGMS 1300 YORK | NEW YORK | NY | 10021 | 133376695 | 3 | 65000 | RESEARCH GRANT |
| CORNELL UNIVERSITY MEDICAL COLLEGE | |||||||
| RESEARCH/SPONSORED PRGMS 1300 YORK | NEW YORK | NY | 10021 | 133376695 | 3 | 200000 | RESEARCH GRANT |
| CORNELL UNIVERSITY MEDICAL COLLEGE | |||||||
| RESEARCH/SPONSORED PRGMS 1300 YORK | NEW YORK | NY | 10021 | 133376695 | 3 | 200000 | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | |||||||
| 44 BINNEY STREET | BOSTON | MA | 02115 | 042263040 | 3 | 55000 | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | |||||||
| 44 BINNEY STREET | BOSTON | MA | 02115 | 042263040 | 3 | 100000 | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | |||||||
| 44 BINNEY STREET | BOSTON | MA | 02115 | 042263040 | 3 | 65000 | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | |||||||
| 44 BINNEY STREET | BOSTON | MA | 02115 | 042263040 | 3 | 110000 | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | |||||||
| 44 BINNEY STREET | BOSTON | MA | 02115 | 042263040 | 3 | 200000 | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | |||||||
| 44 BINNEY STREET | BOSTON | MA | 02115 | 042263040 | 3 | 55000 | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | |||||||
| 44 BINNEY STREET | BOSTON | MA | 02115 | 042263040 | 3 | 55000 | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | |||||||
| 44 BINNEY STREET | BOSTON | MA | 02115 | 042263040 | 3 | 55000 | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | |||||||
| 44 BINNEY STREET | BOSTON | MA | 02115 | 042263040 | 3 | 200000 | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | |||||||
| 44 BINNEY STREET | BOSTON | MA | 02115 | 042263040 | 3 | 65000 | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | |||||||
| 44 BINNEY STREET | BOSTON | MA | 02115 | 042263040 | 3 | 65000 | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | |||||||
| 44 BINNEY STREET | BOSTON | MA | 02115 | 042263040 | 3 | 110000 | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | |||||||
| 44 BINNEY STREET | BOSTON | MA | 02115 | 042263040 | 3 | 65000 | RESEARCH GRANT |
| DANA FARBER CANCER INSTITUTE | |||||||
| 44 BINNEY STREET | BOSTON | MA | 02115 | 042263040 | 3 | 55000 | RESEARCH GRANT |
| DREXEL UNIVERSITY | |||||||
| 497 245 N 15TH STREET NCB ROOM 101 | PHILADELPHIA | PA | 19102 | 231352630 | 3 | 110000 | RESEARCH GRANT |
| DUKE UNIVERSITY | |||||||
| OFFICE OF SPONSORED PROGRAMS 2200 | DURHAM | NC | 27705 | 560532129 | 3 | 65000 | RESEARCH GRANT |
| DUKE UNIVERSITY | |||||||
| OFFICE OF SPONSORED PROGRAMS 2200 | DURHAM | NC | 27705 | 560532129 | 3 | 55000 | RESEARCH GRANT |
| DUKE UNIVERSITY | |||||||
| OFFICE OF SPONSORED PROGRAMS 2200 | DURHAM | NC | 27710 | 560532129 | 3 | 55000 | RESEARCH GRANT |
| DUKE UNIVERSITY | |||||||
| OFFICE OF SPONSORED PROGRAMS 2200 | DURHAM | NC | 27710 | 560532129 | 3 | 110000 | RESEARCH GRANT |
| DUKE UNIVERSITY | |||||||
| OFFICE OF SPONSORED PROGRAMS 2200 | DURHAM | NC | 27710 | 560532129 | 3 | 110000 | RESEARCH GRANT |
| DUKE UNIVERSITY | |||||||
| OFFICE OF SPONSORED PROGRAMS 2200 | DURHAM | NC | 27710 | 560532129 | 3 | 110000 | RESEARCH GRANT |
| DUKE UNIVERSITY | |||||||
| OFFICE OF SPONSORED PROGRAMS 2200 | DURHAM | NC | 27710 | 560532129 | 3 | 110000 | RESEARCH GRANT |
| EMORY UNIVERSITY | |||||||
| OFFICE OF GRANTS RESEARCH 1599 C | ATLANTA | GA | 30322 | 580566256 | 3 | 110000 | RESEARCH GRANT |
| EMORY UNIVERSITY | |||||||
| OFFICE OF GRANTS RESEARCH 1599 C | ATLANTA | GA | 30322 | 580566256 | 3 | 65000 | RESEARCH GRANT |
| FRED HUTCHINSON CANCER RESEARCH CEN | |||||||
| 1100 FAIRVIEW AVENUE NORTH | SEATTLE | WA | 98109 | 237156071 | 3 | 1250000 | RESEARCH GRANT |
| FRED HUTCHINSON CANCER RESEARCH CEN | |||||||
| 1100 FAIRVIEW AVENUE NORTH | SEATTLE | WA | 98109 | 237156071 | 3 | 65000 | RESEARCH GRANT |
| FRED HUTCHINSON CANCER RESEARCH CEN | |||||||
| 1100 FAIRVIEW AVENUE NORTH | SEATTLE | WA | 98109 | 237156071 | 3 | 65000 | RESEARCH GRANT |
| FRED HUTCHINSON CANCER RESEARCH CEN | |||||||
| 1100 FAIRVIEW AVENUE NORTH | SEATTLE | WA | 98109 | 237156071 | 3 | 65000 | RESEARCH GRANT |
| FRED HUTCHINSON CANCER RESEARCH CEN | |||||||
| 1100 FAIRVIEW AVENUE NORTH | SEATTLE | WA | 981091024 | 237156071 | 3 | 55000 | RESEARCH GRANT |
| FRED HUTCHINSON CANCER RESEARCH CEN | |||||||
| 1100 FAIRVIEW AVENUE NORTH | SEATTLE | WA | 981091024 | 237156071 | 3 | 65000 | RESEARCH GRANT |
| FRED HUTCHINSON CANCER RESEARCH CEN | |||||||
| 1100 FAIRVIEW AVENUE NORTH | SEATTLE | WA | 981091024 | 237156071 | 3 | 65000 | RESEARCH GRANT |
| H LEE MOFFITT CANCER CENTER & RESE | |||||||
| SRB-2 12902 MAGNOLIA DRIVE | TAMPA | FL | 33612 | 593238636 | 3 | 200000 | RESEARCH GRANT |
| HARVARD MEDICAL SCHOOL | |||||||
| SPONSORED PROGRAMS ADMINISTRATION | BOSTON | MA | 02115 | 530199180 | 3 | 55000 | RESEARCH GRANT |
| HARVARD MEDICAL SCHOOL | |||||||
| SPONSORED PROGRAMS ADMINISTRATION | BOSTON | MA | 02115 | 530199180 | 3 | 65000 | RESEARCH GRANT |
| HARVARD MEDICAL SCHOOL | |||||||
| SPONSORED PROGRAMS ADMINISTRATION | BOSTON | MA | 02115 | 530199180 | 3 | 65000 | RESEARCH GRANT |
| HARVARD MEDICAL SCHOOL | |||||||
| SPONSORED PROGRAMS ADMINISTRATION | BOSTON | MA | 02115 | 530199180 | 3 | 55000 | RESEARCH GRANT |
| HARVARD MEDICAL SCHOOL | |||||||
| SPONSORED PROGRAMS ADMINISTRATION | BOSTON | MA | 02115 | 530199180 | 3 | 65000 | RESEARCH GRANT |
| HARVARD MEDICAL SCHOOL | |||||||
| SPONSORED PROGRAMS ADMINISTRATION | BOSTON | MA | 02115 | 530199180 | 3 | 65000 | RESEARCH GRANT |
| HARVARD MEDICAL SCHOOL | |||||||
| SPONSORED PROGRAMS ADMINISTRATION | BOSTON | MA | 02115 | 530199180 | 3 | 110000 | RESEARCH GRANT |
| HARVARD UNIVERSITY SCHOOL OF PUBLIC | |||||||
| FXB BUILDING ROOM 205 651 HUNTINGTO | BOSTON | MA | 02115 | 530199180 | 3 | 55000 | RESEARCH GRANT |
| HARVARD UNIVERSITY SCHOOL OF PUBLIC | |||||||
| FXB BUILDING ROOM 205 651 HUNTINGTO | BOSTON | MA | 02115 | 530199180 | 3 | 55000 | RESEARCH GRANT |
| HEALTH RESEARCH INCORPORATED ROSWE | |||||||
| ELM CARLTON STREETS | BUFFALO | NY | 14263 | 141402155 | 3 | 110000 | RESEARCH GRANT |
| HEALTH RESEARCH INCORPORATED ROSWE | |||||||
| ELM CARLTON STREETS | BUFFALO | NY | 14263 | 042158520 | 3 | 100000 | RESEARCH GRANT |
| IMMUNE DISEASE INSTITUTE INC | |||||||
| CLSB-THIRD FLOOR 3 BLACKFAN CIRCLE | BOSTON | MA | 02115 | 042158520 | 3 | 65000 | RESEARCH GRANT |
| IMMUNE DISEASE INSTITUTE INC | |||||||
| CLSB-THIRD FLOOR 3 BLACKFAN CIRCLE | BOSTON | MA | 02115 | 042158520 | 3 | 65000 | RESEARCH GRANT |
| IMMUNE DISEASE INSTITUTE INC | |||||||
| CLSB-THIRD FLOOR 3 BLACKFAN CIRCLE | BOSTON | MA | 02115 | 042158520 | 3 | 200000 | RESEARCH GRANT |
| IMMUNE DISEASE INSTITUTE INC | |||||||
| CLSB-THIRD FLOOR 3 BLACKFAN CIRCLE | BOSTON | MA | 02115 | 042158520 | 3 | 55000 | RESEARCH GRANT |
| IMMUNE DISEASE INSTITUTE INC | |||||||
| CLSB-THIRD FLOOR 3 BLACKFAN CIRCLE | BOSTON | MA | 02115 | 042158520 | 3 | 55000 | RESEARCH GRANT |
| IMMUNE DISEASE INSTITUTE INC | |||||||
| CLSB-THIRD FLOOR 3 BLACKFAN CIRCLE | BOSTON | MA | 02115 | 042158520 | 3 | 65000 | RESEARCH GRANT |
| IMMUNE DISEASE INSTITUTE INC | |||||||
| CLSB-THIRD FLOOR 3 BLACKFAN CIRCLE | BOSTON | MA | 02115 | 042158520 | 3 | 55000 | RESEARCH GRANT |
| IMMUNE DISEASE INSTITUTE INC | |||||||
| CLSB-THIRD FLOOR 3 BLACKFAN CIRCLE | BOSTON | MA | 02115 | 042158520 | 3 | 55000 | RESEARCH GRANT |
| JOAN & SANFORD I WEILL MEDICAL COL | |||||||
| 435 EAST 70TH STREET | NEW YORK | NY | 10021 | 133376695 | 3 | 65000 | RESEARCH GRANT |
| JOAN & SANFORD I WEILL MEDICAL COL | |||||||
| 435 EAST 70TH STREET | NEW YORK | NY | 10065 | 133376695 | 3 | 200000 | RESEARCH GRANT |
| JOAN & SANFORD I WEILL MEDICAL COL | |||||||
| 435 EAST 70TH STREET | NEW YORK | NY | 10021 | 133376695 | 3 | 110000 | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY | |||||||
| RESEARCH ACCOUNTING 1101 EAST 33RD | BALTIMORE | MD | 21231 | 520595110 | 3 | 110000 | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY | |||||||
| RESEARCH ACCOUNTING 1101 EAST 33RD | BALTIMORE | MD | 21218 | 520595110 | 3 | 200000 | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY | |||||||
| RESEARCH ACCOUNTING 1101 EAST 33RD | BALTIMORE | MD | 21218 | 520595110 | 3 | 200000 | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY | |||||||
| RESEARCH ACCOUNTING 1101 EAST 33RD | BALTIMORE | MD | 21218 | 520595110 | 3 | 65000 | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY | |||||||
| RESEARCH ACCOUNTING 1101 EAST 33RD | BALTIMORE | MD | 21218 | 520595110 | 3 | 200000 | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY | |||||||
| CRB I ROOM 243 1650 ORLEANS STREET | BALTIMORE | MD | 21231 | 520595110 | 3 | 110000 | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY | |||||||
| CRB I ROOM 243 1650 ORLEANS STREET | BALTIMORE | MD | 21287 | 520595110 | 3 | 110000 | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY SCHOOL OF | |||||||
| CRB I ROOM 243 1650 ORLEANS STREET | BALTIMORE | MD | 21231 | 520595110 | 3 | 200000 | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY SCHOOL OF | |||||||
| 733 N BROADWAY BRB 473 | BALTIMORE | MD | 21205 | 520595110 | 3 | 110000 | RESEARCH GRANT |
| JOHNS HOPKINS UNIVERSITY SCHOOL OF | |||||||
| 550 NORTH BROADWAY SUITE 11 | BALTIMORE | MD | 21205 | 520595110 | 3 | 200000 | RESEARCH GRANT |
| LELAND STANFORD JUNIOR UNIVERSITY ( | |||||||
| 5175 269 CAMPUS DRIVE CCSR 4215 | BIG OAK FLAT | CA | 95305 | 941156365 | 3 | 200000 | RESEARCH GRANT |
| MASSACHUSETTS GENERAL HOSPITAL (THE | |||||||
| RESEARCH FINANCE 50 STANIFORD STRE | BOSTON | MA | 021142554 | 041564655 | 3 | 55000 | RESEARCH GRANT |
| MASSACHUSETTS GENERAL HOSPITAL (THE | |||||||
| RESEARCH FINANCE 50 STANIFORD STRE | BOSTON | MA | 021142554 | 041564655 | 3 | 55000 | RESEARCH GRANT |
| MASSACHUSETTS GENERAL HOSPITAL (THE | |||||||
| RESEARCH FINANCE 50 STANIFORD STRE | BOSTON | MA | 02114 | 041564655 | 3 | 65000 | RESEARCH GRANT |
| MASSACHUSETTS GENERAL HOSPITAL (THE | |||||||
| RESEARCH FINANCE 50 STANIFORD STRE | BOSTON | MA | 02114 | 041564655 | 3 | 55000 | RESEARCH GRANT |
| MASSACHUSETTS GENERAL HOSPITAL (THE | |||||||
| RESEARCH FINANCE 50 STANIFORD STRE | BOSTON | MA | 02114 | 041564655 | 3 | 65000 | RESEARCH GRANT |
| MASSACHUSETTS GENERAL HOSPITAL (THE | |||||||
| RESEARCH FINANCE 50 STANIFORD STRE | BOSTON | MA | 02114 | 041564655 | 3 | 110000 | RESEARCH GRANT |
| MASSACHUSETTS GENERAL HOSPITAL (THE | |||||||
| ROOM 7330 149 13TH STREET | CHARLESTOWN | MA | 02129 | 041564655 | 3 | 65000 | RESEARCH GRANT |
| MASSACHUSETTS INSTITUTE OF TECHNOLO | |||||||
| 77 MASSACHUSETTS AVENUE E17-52 | CAMBRIDGE | MA | 02139 | 042103594 | 3 | 55000 | RESEARCH GRANT |
| MASSACHUSETTS INSTITUTE OF TECHNOLO | |||||||
| 77 MASSACHUSETTS AVENUE E17-52 | CAMBRIDGE | MA | 02139 | 042103594 | 3 | 55000 | RESEARCH GRANT |
| MASSACHUSETTS INSTITUTE OF TECHNOLO | |||||||
| 77 MASSACHUSETTS AVENUE E17-52 | CAMBRIDGE | MA | 02139 | 042103594 | 3 | 55000 | RESEARCH GRANT |
| MASSACHUSETTS INSTITUTE OF TECHNOLO | |||||||
| 77 MASSACHUSETTS AVENUE E17-52 | CAMBRIDGE | MA | 02139 | 042103594 | 3 | 55000 | RESEARCH GRANT |
| MAYO CLINIC & FOUNDATION | |||||||
| RESEARCH ADMINISTRATIVE SERVICES 2 | ROCHESTER | MN | 55905 | 411506440 | 3 | 100000 | RESEARCH GRANT |
| MAYO CLINIC & FOUNDATION | |||||||
| RESEARCH ADMINISTRATIVE SERVICES 2 | ROCHESTER | MN | 55905 | 411506440 | 3 | 110000 | RESEARCH GRANT |
| MAYO CLINIC & FOUNDATION | |||||||
| RESEARCH ADMINISTRATIVE SERVICES 2 | ROCHESTER | MN | 55905 | 411506440 | 3 | 200000 | RESEARCH GRANT |
| MAYO CLINIC & FOUNDATION | |||||||
| RESEARCH ADMINISTRATIVE SERVICES 2 | ROCHESTER | MN | 55905 | 411506440 | 3 | 55000 | RESEARCH GRANT |
| MAYO CLINIC & FOUNDATION | |||||||
| RESEARCH ADMINISTRATIVE SERVICES 2 | ROCHESTER | MN | 55905 | 411506440 | 3 | 110000 | RESEARCH GRANT |
| MAYO CLINIC & FOUNDATION | |||||||
| RESEARCH ADMINISTRATIVE SERVICES 2 | ROCHESTER | MN | 55905 | 411506440 | 3 | 200000 | RESEARCH GRANT |
| MAYO CLINIC ARIZONA DBA MAYO CLI | |||||||
| 13400 EAST SHEA BOULEVARD MCCRB 3-0 | SCOTTSDALE | AZ | 85259 | 860800150 | 3 | 200000 | RESEARCH GRANT |
| MEDICAL COLLEGE OF WISCONSIN | |||||||
| MEDICAL COLLEGE OF WISCONSIN 8701 W | MILWAUKEE | WI | 53226 | 390806261 | 3 | 110000 | RESEARCH GRANT |
| MEMORIAL SLOAN-KETTERING CANCER CEN | |||||||
| 1275 YORK AVEBOX 4 | NEW YORK | NY | 10021 | 912154267 | 3 | 55000 | RESEARCH GRANT |
| MEMORIAL SLOAN-KETTERING CANCER CEN | |||||||
| 1275 YORK AVEBOX 4 | NEW YORK | NY | 10065 | 912154267 | 3 | 200000 | RESEARCH GRANT |
| MEMORIAL SLOAN-KETTERING CANCER CEN | |||||||
| 1275 YORK AVEBOX 4 | NEW YORK | NY | 10021 | 912154267 | 3 | 200000 | RESEARCH GRANT |
| MEMORIAL SLOAN-KETTERING CANCER CEN | |||||||
| 1275 YORK AVEBOX 4 | NEW YORK | NY | 10065 | 912154267 | 3 | 200000 | RESEARCH GRANT |
| MEMORIAL SLOAN-KETTERING CANCER CEN | |||||||
| 1275 YORK AVEBOX 4 | NEW YORK | NY | 10021 | 912154267 | 3 | 1250000 | RESEARCH GRANT |
| MEMORIAL SLOAN-KETTERING CANCER CEN | |||||||
| 1275 YORK AVEBOX 4 | NEW YORK | NY | 10021 | 912154267 | 3 | 200000 | RESEARCH GRANT |
| MEMORIAL SLOAN-KETTERING CANCER CEN | |||||||
| 1275 YORK AVEBOX 4 | NEW YORK | NY | 10021 | 912154267 | 3 | 55000 | RESEARCH GRANT |
| MEMORIAL SLOAN-KETTERING CANCER CEN | |||||||
| 1275 YORK AVEBOX 4 | NEW YORK | NY | 10065 | 912154267 | 3 | 55000 | RESEARCH GRANT |
| NEVADA CANCER INSTITUTE | |||||||
| ONE BREAKTHROUGH WAY | LAS VEGAS | NV | 89135 | 043632553 | 3 | 65000 | RESEARCH GRANT |
| NEW ENGLAND MEDICAL CENTER HOSPITAL | |||||||
| 5609 750 WASHINGTON | BOSTON | MA | 02111 | 043400617 | 3 | 55000 | RESEARCH GRANT |
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | |||||||
| 550 FIRST AVENUE GBH-SC1-47 | NEW YORK | NY | 10016 | 136171197 | 3 | 200000 | RESEARCH GRANT |
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | |||||||
| 550 FIRST AVENUE GBH-SC1-47 | NEW YORK | NY | 10016 | 136171197 | 3 | 55000 | RESEARCH GRANT |
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | |||||||
| 550 FIRST AVENUE GBH-SC1-47 | NEW YORK | NY | 10016 | 136171197 | 3 | 65000 | RESEARCH GRANT |
| NEW YORK UNIVERSITY SCHOOL OF MEDIC | |||||||
| 550 FIRST AVENUE GBH-SC1-47 | NEW YORK | NY | 10016 | 136171197 | 3 | 110000 | RESEARCH GRANT |
| NORTHWESTERN UNIVERSITY - CHICAGO C | |||||||
| 303 EAST SUPERIOR STREET LURIE BUI | CHICAGO | IL | 60611 | 362656113 | 3 | 200000 | RESEARCH GRANT |
| NORTHWESTERN UNIVERSITY - CHICAGO C | |||||||
| 303 EAST SUPERIOR STREET LURIE BUI | CHICAGO | IL | 60611 | 362656113 | 3 | 65000 | RESEARCH GRANT |
| NORTHWESTERN UNIVERSITY - CHICAGO C | |||||||
| 303 EAST SUPERIOR STREET LURIE BUI | CHICAGO | IL | 60611 | 362656113 | 3 | 55000 | RESEARCH GRANT |
| NORTHWESTERN UNIVERSITY - CHICAGO C | |||||||
| 303 EAST SUPERIOR STREET LURIE BUI | CHICAGO | IL | 60611 | 362656113 | 3 | 200000 | RESEARCH GRANT |
| NORTHWESTERN UNIVERSITY - CHICAGO C | |||||||
| 303 EAST SUPERIOR STREET LURIE BUI | CHICAGO | IL | 60611 | 362656113 | 3 | 1250000 | RESEARCH GRANT |
| OHIO STATE UNIVERSITY | |||||||
| RESEARCH FOUNDATION 1960 KENNY ROA | COLUMBUS | OH | 432101063 | 316401599 | 3 | 1250000 | RESEARCH GRANT |
| OHIO STATE UNIVERSITY | |||||||
| 892 BIOMEDICAL RESEARCH TOWER 460 | COLUMBUS | OH | 432102207 | 316401599 | 3 | 110000 | RESEARCH GRANT |
| OREGON HEALTH & SCIENCE UNIVERSITY | |||||||
| 3181 SW SAM JACKSON PARK RD L5 | PORTLAND | OR | 97239 | 237083114 | 3 | 110000 | RESEARCH GRANT |
| OREGON HEALTH & SCIENCE UNIVERSITY | |||||||
| SPONSORED PROJECTS ADMINISTRATION | PORTLAND | OR | 97201 | 237083114 | 3 | 1250000 | RESEARCH GRANT |
| OREGON HEALTH & SCIENCE UNIVERSITY | |||||||
| L103A 3181 SW SAM JACKSON PARK RD | PORTLAND | OR | 972393098 | 237083114 | 3 | 110000 | RESEARCH GRANT |
| ROCKEFELLER UNIVERSITY | |||||||
| 1230 YORK AVENUE BOX 2 | NEW YORK | NY | 10065 | 131624158 | 3 | 55000 | RESEARCH GRANT |
| ROCKEFELLER UNIVERSITY | |||||||
| 1230 YORK AVENUE BOX 2 | NEW YORK | NY | 10065 | 131624158 | 3 | 55000 | RESEARCH GRANT |
| ROCKEFELLER UNIVERSITY | |||||||
| 1230 YORK AVENUE BOX 2 | NEW YORK | NY | 10065 | 131624158 | 3 | 110000 | RESEARCH GRANT |
| ROCKEFELLER UNIVERSITY | |||||||
| 1230 YORK AVENUE BOX 2 | NEW YORK CITY | NY | 10065 | 131624158 | 3 | 55000 | RESEARCH GRANT |
| ROCKEFELLER UNIVERSITY | |||||||
| 1230 YORK AVENUE BOX 2 | NEW YORK CITY | NY | 10065 | 131624158 | 3 | 55000 | RESEARCH GRANT |
| STANFORD UNIVERSITY | |||||||
| STANFORD CANCER CENTER | PALO ALTO | CA | 94304 | 941156365 | 3 | 1250000 | RESEARCH GRANT |
| STANFORD UNIVERSITY | |||||||
| PO BOX 44253 | SAN FRANCISCO | CA | 941444253 | 941156365 | 3 | 65000 | RESEARCH GRANT |
| STANFORD UNIVERSITY | |||||||
| PO BOX 44253 | SAN FRANCISCO | CA | 941444253 | 941156365 | 3 | 200000 | RESEARCH GRANT |
| STANFORD UNIVERSITY | |||||||
| PO BOX 44253 | SAN FRANCISCO | CA | 941444253 | 941156365 | 3 | 200000 | RESEARCH GRANT |
| STANFORD UNIVERSITY | |||||||
| PO BOX 44253 | SAN FRANCISCO | CA | 941444253 | 941156365 | 3 | 65000 | RESEARCH GRANT |
| STANFORD UNIVERSITY | |||||||
| 5152 CCSR-SOUTH RM 1255269 CAMPUS | STANFORD | CA | 94305 | 941156365 | 3 | 110000 | RESEARCH GRANT |
| STANFORD UNIVERSITY | |||||||
| 5152 269 CAMPUS DRIVE 1245CCSR SOU | STANFORD | CA | 943055152 | 941156365 | 3 | 200000 | RESEARCH GRANT |
| STANFORD UNIVERSITY | |||||||
| MC 5149 269 CAMPUS DRIVECCSR 1215A | STANFORD | CA | 943055149 | 941156365 | 3 | 110000 | RESEARCH GRANT |
| STANFORD UNIVERSITY | |||||||
| 5166 269 CAMPUS DRIVE CCSR 2215 | STANFORD | CA | 94305 | 941156365 | 3 | 200000 | RESEARCH GRANT |
| STOWERS INSTITUTE FOR MEDICAL RESEA | |||||||
| 1000 EAST 50TH STREET | KANSAS CITY | MO | 64110 | 436384454 | 3 | 55000 | RESEARCH GRANT |
| STOWERS INSTITUTE FOR MEDICAL RESEA | |||||||
| 1000 EAST 50TH STREET | KANSAS CITY | MO | 64110 | 436384454 | 3 | 55000 | RESEARCH GRANT |
| STOWERS INSTITUTE FOR MEDICAL RESEA | |||||||
| 1000 EAST 50TH STREET | KANSAS CITY | MO | 64110 | 436384454 | 3 | 65000 | RESEARCH GRANT |
| TBD | |||||||
| 1311 MAMARONECK AVENUE | WHITE PLAINS | NY | 10605 | N/A | 100000 | RESEARCH GRANT | |
| TBD | |||||||
| 1311 MAMARONECK AVENUE | WHITE PLAINS | NY | 10605 | N/A | 431000 | RESEARCH GRANT | |
| THE SALK INSTITUTE FOR BIOLOGICAL S | |||||||
| 10010 NORTH TORREY PINES ROAD | LA JOLLA | CA | 920371099 | 952160097 | 3 | 55000 | RESEARCH GRANT |
| THE SCRIPPS RESEARCH INSTITUTE | |||||||
| MB-3 10550 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | 330435954 | 3 | 110000 | RESEARCH GRANT |
| THE SCRIPPS RESEARCH INSTITUTE | |||||||
| MB-3 10550 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | 330435954 | 3 | 110000 | RESEARCH GRANT |
| THE SCRIPPS RESEARCH INSTITUTE | |||||||
| MB-3 10550 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | 330435954 | 3 | 55000 | RESEARCH GRANT |
| THE SCRIPPS RESEARCH INSTITUTE | |||||||
| MB-3 10550 NORTH TORREY PINES ROAD | LA JOLLA | CA | 92037 | 330435954 | 3 | 65000 | RESEARCH GRANT |
| UMDNJ--ROBERT WOOD JOHNSON MEDICAL | |||||||
| CENTER FOR ADVANCED BIOTECHNOLOGY A | PISCATAWAY | NJ | 08854 | 222552329 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF ALABAMA AT BIRMINGHAM | |||||||
| WTI 520C 1530 3RD AVENUE SOUTH | BIRMINGHAM | AL | 35294 | 636005396 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF ARIZONA | |||||||
| LIFE SCIENCES SOUTH BLDG RM 414 10 | TUCSON | AZ | 857210106 | 742652689 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA BERKELEY | |||||||
| UNIVERSITY OF CALIFORNIA BERKELEY | BERKELEY | CA | 947203200 | 946002123 | 3 | 65000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA BERKELEY | |||||||
| THE REGENTS OF THE UNIVERSITY OF CA | BERKELEY | CA | 947201103 | 946002123 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA BERKELEY | |||||||
| THE REGENTS OF THE UNIVERSITY OF CA | BERKELEY | CA | 947201103 | 946002123 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA LOS ANGEL | |||||||
| REGENTS OF THE UNIVERSITY OF CALIFO | LOS ANGELES | CA | 900951735 | 956006143 | 3 | 65000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA LOS ANGEL | |||||||
| MBI RM 659 JAMES BOWIE LAB UCLA61 | LOS ANGELES | CA | 900951570 | 956006143 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA LOS ANGEL | |||||||
| CHS 23-234 650 CE YOUNG DRIVE SOUTH | LOS ANGELES | CA | 90095 | 956006143 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA LOS ANGEL | |||||||
| 10833 LECONTE AVENUECENTER FOR HEAL | LOS ANGELES | CA | 900951678 | 956006143 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN DIEGO | |||||||
| UCSD/OFF CTRCTS-GRTS ADMIN 9500 GI | LA JOLLA | CA | 920930934 | 956006144 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN DIEGO | |||||||
| UCSD/OFF CTRCTS-GRTS ADMIN 9500 GI | LA JOLLA | CA | 920930934 | 956006144 | 3 | 65000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | |||||||
| ROOM HSE1000A BOX 0414UNIVERSITY O | SAN FRANCISCO | CA | 94143 | 946036493 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | |||||||
| 513 PARNASSUS BOX 05 | SAN FRANCISCO | CA | 94143 | 946036493 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | |||||||
| BOX 0414 513 PARNASSUS AVENUEROOM H | SAN FRANCISCO | CA | 941430414 | 946036493 | 3 | 65000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | |||||||
| BOX 0519 513 PARNASSUS AVENUEHSE 30 | SAN FRANCISCO | CA | 94143 | 946036493 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | |||||||
| N412F GENENTECH HALL | SAN FRANCISCO | CA | 941582517 | 946036493 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | |||||||
| 1270 505 PARNASSUS AVE | SAN FRANCISCO | CA | 94143 | 946036493 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | |||||||
| 600 16TH STREET BOX 22 | SAN FRANCISCO | CA | 94158 | 946036493 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | |||||||
| 505 PARNASSUS AVENUESUITE M1286 B | SAN FRANCISCO | CA | 94143 | 946036493 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | |||||||
| 1 IRVING STREET AC- | SAN FRANCISCO | CA | 941430441 | 946036493 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | |||||||
| 513 PARNASSUS AVE BOX 0519 | SAN FRANCISCO | CA | 941430519 | 946036493 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | |||||||
| REGENTS OF THE UNIVERSITY OF CALIFO | SAN FRANCISCO | CA | 941430897 | 946036493 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIA SAN FRANC | |||||||
| REGENTS OF THE UNIVERSITY OF CALIFO | SAN FRANCISCO | CA | 941430897 | 946036493 | 3 | 65000 | RESEARCH GRANT |
| UNIVERSITY OF CALIFORNIASAN FRANCI | |||||||
| 1855 FOLSOM STREET SUITE 425 BOX | SAN FRANCISCO | CA | 941430897 | 946036493 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF CHICAGO | |||||||
| 5841 SOUTH MARYLAND AVENUE MC 1089 | CHICAGO | IL | 60637 | 362177139 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF CHICAGO | |||||||
| 5841 SOUTH MARYLAND AVENUE MC 1089 | CHICAGO | IL | 60637 | 362177139 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF CHICAGO | |||||||
| 5841 SOUTH MARYLAND AVENUE MC 1089 | CHICAGO | IL | 60637 | 362177139 | 3 | 1050000 | RESEARCH GRANT |
| UNIVERSITY OF CHICAGO | |||||||
| UNIVERSITY RESEARCH ADMIN 970 EAST | CHICAGO | IL | 606371470 | 362177139 | 3 | 65000 | RESEARCH GRANT |
| UNIVERSITY OF CINCINNATI | |||||||
| UNIVERSITY OF CINCINNATI MEDICAL CE | CINCINNATI | OH | 452670524 | 316000989 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF COLORADO HEALTH SCIEN | |||||||
| PO BOX 6508 FITZSIMONS BLDG 500 | AURORA | CO | 800450508 | 846000555 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF COLORADO UNIVERSITY | |||||||
| 8101 PO BOX 6511 AURORA CO | AURORA | CO | 80045 | 846000555 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF ILLINOIS | |||||||
| BOARD OF TRUSTEES 809 S MARSHFIEL | CHICAGO | IL | 606127205 | 376000511 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF ILLINOIS - CHICAGO | |||||||
| MAIL CODE 734 COLLEGE OF MEDICINE | CHICAGO | IL | 606123725 | 362177139 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF IOWA | |||||||
| 3-501 BOWEN SCIENCE BUILDING 51 NEW | CORALVILLE | IA | 52241 | 426004813 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF MARYLAND BALTIMORE | |||||||
| ATTN MGR RESTRICTED FUNDS ACCOUNT | BALTIMORE | MD | 212036428 | 526002033 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF MASSACHUSETTS MEDICAL | |||||||
| 364 PLANTATION STREET LRB ROOM 622 | WORCESTER | MA | 01605 | 043167352 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF MASSACHUSETTS MEDICAL | |||||||
| 364 PLANTATION STREET LRB ROOM 622 | WORCESTER | MA | 01605 | 043167352 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF MASSACHUSETTS MEDICAL | |||||||
| 364 PLANTATION STREET LRB ROOM 622 | WORCESTER | MA | 01605 | 043167352 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF MASSACHUSETTS MEDICAL | |||||||
| 364 PLANTATION STREET LRB ROOM 622 | WORCESTER | MA | 01605 | 043167352 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF MASSACHUSETTS MEDICAL | |||||||
| 364 PLANTATION STREET LRB ROOM 622 | WORCHESTER | MA | 01655 | 043167352 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF MIAMI SCHOOL OF MEDIC | |||||||
| PO BOX 016960 1611 NW 12TH AVENUE | MIAMI | FL | 33136 | 590624458 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | |||||||
| DIVISION OF HEMATOLOGY / ONCOLOGYD | ANN ARBOR | MI | 481090848 | 386006309 | 3 | 65000 | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | |||||||
| 2200 109 ZINA PITCHER PLACE - ROOM | ANN ARBOR | MI | 48109 | 386006309 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | |||||||
| 6308 CCGC SPC 5942 1500 EAST MEDIC | ANN ARBOR | MI | 481095942 | 386006309 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | |||||||
| 1500 E MEDICAL CENTER DRIVE4312 CA | ANN ARBOR | MI | 48109 | 386006309 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | |||||||
| 3003 S STATE ST -3089 WOLVERINE TO | ANN ARBOR | MI | 481095942 | 386006309 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | |||||||
| 3003 S STATE ST -3089 WOLVERINE TO | ANN ARBOR | MI | 481091287 | 386006309 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | |||||||
| 3003 S STATE ST -3089 WOLVERINE TO | ANN ARBOR | MI | 481091274 | 386006309 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF MICHIGAN | |||||||
| 3003 S STATE ST -3089 WOLVERINE TO | ANN ARBOR | MI | 481091287 | 386006309 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF MINNESOTA | |||||||
| SPONSORED PROGRAMS ADMINISTRATION | MINNEAPOLIS | MN | 55455 | 416007513 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF MINNESOTA - TWIN CITI | |||||||
| 6-155 JACKSON HALL 321 CHURCH STREE | MINNEAPOLIS | MN | 554551214 | 416007513 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF MINNESOTA - TWIN CITI | |||||||
| MMC 109 420 DELAWARE STREET SE | MINNEAPOLIS | MN | 55455 | 416007513 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF MINNESOTA - TWIN CITI | |||||||
| 6-256 BSBE 312 CHURCH ST SE | MINNEAPOLIS | MN | 55455 | 416007513 | 3 | 65000 | RESEARCH GRANT |
| UNIVERSITY OF MINNESOTA TWIN CITIE | |||||||
| 312 CHURCH ST SE 6-116 NILS HASSE | MINNEAPOLIS | MN | 55405 | 416007513 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF MINNESOTA-TWIN CITIES | |||||||
| SPONSORED PROGRAMS ADMINISTRATION | MINNEAPOLIS | MN | 55455 | 416007513 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF NORTH CAROLINA AT CHA | |||||||
| 715 MEJB CB 7290 | CHAPEL HILL | NC | 275997290 | 566001393 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF NORTH CAROLINA AT CHA | |||||||
| 715 MEJB CB 7290 | CHAPEL HILL | NC | 27599 | 566001393 | 3 | 65000 | RESEARCH GRANT |
| UNIVERSITY OF NORTH CAROLINA AT CHA | |||||||
| CB 7295 102 MASON FARM ROAD | CHAPEL HILL | NC | 27599 | 566001393 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF NORTH CAROLINA AT CHA | |||||||
| 104 AIRPORT DRIVE SUITE 2200 | CHAPEL HILL | NC | 275991350 | 566001393 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF NORTH CAROLINA AT CHA | |||||||
| 101 MANNING DRIVE | CHAPEL HILL | NC | 27514 | 566001393 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF OREGON | |||||||
| INSTITUTE OF NEUROSCIENCE 1254 UNIV | EUGENE | OR | 97403 | 936001786 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF OREGON | |||||||
| 1229 INSTITUTE OF MOLECULAR BIOLOGY | EUGENE | OR | 974031229 | 936001786 | 3 | 65000 | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | |||||||
| BRB 2/3 ROOM 720 421 CURIE BOULEVAR | PHILADELPHIA | PA | 19104 | 231352685 | 3 | 65000 | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | |||||||
| 2 MALONEY 3600 SPRUCE STREET | PHILADELPHIA | PA | 19104 | 231352685 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | |||||||
| STELLAR CHANCE BUILDING 422 CURIE B | PHILADELPHIA | PA | 19104 | 231352685 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | |||||||
| RESEARCH SERVICES P-221 FRANKLIN B | PHILADELPHIA | PA | 191046205 | 231352685 | 3 | 65000 | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | |||||||
| RESEARCH SERVICES P-221 FRANKLIN B | PHILADELPHIA | PA | 191046205 | 231352685 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | |||||||
| RESEARCH SERVICES P-221 FRANKLIN B | PHILADELPHIA | PA | 191046205 | 231352685 | 3 | 65000 | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | |||||||
| 372E OLD VETPATHOBIOLOGY3800 SPRUCE | PHILDELPHIA | PA | 19014 | 231352685 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | |||||||
| RESEARCH SERVICES P-221 FRANKLIN B | PHILADELPHIA | PA | 191046205 | 231352685 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | |||||||
| 421 CURIE BOULEVARD | PHILADELPHIA | PA | 19104 | 231352685 | 3 | 1250000 | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | |||||||
| RESEARCH SERVICES P-221 FRANKLIN B | PHILADELPHIA | PA | 191046205 | 231352685 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | |||||||
| RESEARCH SERVICES P-221 FRANKLIN B | PHILADELPHIA | PA | 191046205 | 231352685 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | |||||||
| RESEARCH SERVICES P-221 FRANKLIN B | PHILADELPHIA | PA | 191046205 | 231352685 | 3 | 65000 | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | |||||||
| RESEARCH SERVICES P-221 FRANKLIN B | PHILADELPHIA | PA | 191046205 | 231352685 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | |||||||
| 454 BRBII/III 421 CURIE BLVD | PHILADELPHIA | PA | 19104 | 231352685 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF PENNSYLVANIA | |||||||
| RM 264/266 JOHN MORGAN BUILDING 37 | PHILADELPHIA | PA | 19104 | 231352685 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF PITTSBURGH | |||||||
| 5117 CENTRE AVENUE SUITE 119A | PITTSBURGH | PA | 15213 | 250965591 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF PITTSBURGH | |||||||
| 5117 CENTER AVEROOM 242EHILLMAN C | PITTSBURGH | PA | 15213 | 250965591 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF PITTSBURGH | |||||||
| UPMC CANCER PAVILION 5685150 CEN | PITTSBURGH | PA | 15232 | 250965591 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF PITTSBURGH | |||||||
| 218A HILLMAN RESEARCH PAVILION 511 | PITTSBURGH | PA | 15213 | 250965591 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF ROCHESTER | |||||||
| JAMES P WILMOT CANCER CENTER601 E | ROCHESTER | NY | 14642 | 160473209 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF ROCHESTER | |||||||
| OFFICE OF RESEARCH 517 HYLAN BUILD | ROCHESTER | NY | 14642 | 160473209 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF ROCHESTER | |||||||
| 601 ELMWOOD AVENUE BOX 633 KMRB 2 | ROCHESTER | NY | 14642 | 160473209 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF ROCHESTER | |||||||
| 517 HYLAN BUILDING BOX 270140 | ROCHESTER | NY | 14642 | 160473209 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | |||||||
| SOUTHWESTERN GRANTS MANAGEMENT PO | DALLAS | TX | 752841753 | 760300816 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | |||||||
| MD ANDERSON CANCER CENTER 1515 HOL | HOUSTON | TX | 770302399 | 760300816 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | |||||||
| MD ANDERSON CANCER CENTER 1515 HOL | HOUSTON | TX | 77030 | 760300816 | 3 | 1250000 | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | |||||||
| MD ANDERSON CANCER CENTER 1515 HOL | HOUSTON | TX | 770302399 | 760300816 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | |||||||
| MD ANDERSON CANCER CENTER 1515 HOL | HOUSTON | TX | 770302399 | 760300816 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | |||||||
| MD ANDERSON CANCER CENTER 1515 HOL | HOUSTON | TX | 770302399 | 760300816 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | |||||||
| MD ANDERSON CANCER CENTER 1515 HOL | HOUSTON | TX | 772301402 | 760300816 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | |||||||
| MD ANDERSON CANCER CENTER 1515 HOL | HOUSTON | TX | 77054 | 760300816 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | |||||||
| MD ANDERSON CANCER CENTER 1515 HOL | HOUSTON | TX | 77030 | 760300816 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | |||||||
| MD ANDERSON CANCER CENTER 1515 HOL | HOUSTON | TX | 77030 | 760300816 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | |||||||
| MD ANDERSON CANCER CENTER 1515 HOL | HOUSTON | TX | 77030 | 760300816 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | |||||||
| MD ANDERSON CANCER CENTER 1515 HOL | HOUSTON | TX | 770302399 | 760300816 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF TEXAS | |||||||
| 15355 LAMDA DRIVE | SAN ANTONIO | TX | 782453207 | 760300816 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF TEXAS SAN ANTONIO | |||||||
| OFFICE OF SPONSORED PROGRAMS 7703 | SAN ANTONIO | TX | 782293900 | 741717115 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF UTAH | |||||||
| 391 CHIPETA WAY SUIT | SALT LAKE CITY | UT | 84108 | 876000525 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF UTAH | |||||||
| UNIVERSITY OF UTAH SCHOOL OF MEDICI | SALT LAKE CITY | UT | 84132 | 876000525 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF UTAH | |||||||
| GRANTS CONTRACTS 201 S PRESIDENT | SALT LAKE CITY | UT | 841129020 | 876000525 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF VIRGINIA | |||||||
| JORDAN HALL ROOM 4233 1300 JEFFERS | CHARLOTTESVILLE | VA | 22908 | 546001796 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF WASHINGTON | |||||||
| BOX 357710 DIVISION OF HEMATOLOGYUN | SEATTLE | WA | 98195 | 916001537 | 3 | 200000 | RESEARCH GRANT |
| UNIVERSITY OF WASHINGTON | |||||||
| SEATTLE CANCER CARE ALLIANCE825 EA | SEATTLE | WA | 98109 | 916001537 | 3 | 110000 | RESEARCH GRANT |
| UNIVERSITY OF WASHINGTON | |||||||
| OFFICE OF SPONSORED PROJECTS 1100 | SEATTLE | WA | 98105 | 916001537 | 3 | 55000 | RESEARCH GRANT |
| UNIVERSITY OF WASHINGTON | |||||||
| OFFICE OF SPONSORED PROJECTS 1100 | SEATTLE | WA | 98105 | 916001537 | 3 | 65000 | RESEARCH GRANT |
| VANDERBILT UNIVERSITY MEDICAL CENTE | |||||||
| 777 PRB 2220 PIERCE AVE | NASHVILLE | TN | 372326307 | 620476822 | 3 | 200000 | RESEARCH GRANT |
| VIRGINIA COMMONWEALTH UNIVERSITY | |||||||
| 401 COLLEGE STREET PO BOX 9800 | RICHMOND | VA | 232980035 | 546001758 | 3 | 200000 | RESEARCH GRANT |
| WASHINGTON UNIVERSITY IN ST LOUIS | |||||||
| BOX 8118 660 S EUCLID AVE | ST LOUIS | MO | 63110 | 430653611 | 3 | 65000 | RESEARCH GRANT |
| WASHINGTON UNIVERSITY IN ST LOUIS | |||||||
| BOX 8118 660 S EUCLID AVE | ST LOUIS | MO | 63110 | 430653611 | 3 | 200000 | RESEARCH GRANT |
| WASHINGTON UNIVERSITY IN ST LOUIS | |||||||
| BOX 8118 660 S EUCLID AVE | ST LOUIS | MO | 63110 | 430653611 | 3 | 200000 | RESEARCH GRANT |
| WASHINGTON UNIVERSITY IN ST LOUIS | |||||||
| BOX 8118 660 S EUCLID AVE | ST LOUIS | MO | 63110 | 430653611 | 3 | 55000 | RESEARCH GRANT |
| WASHINGTON UNIVERSITY IN ST LOUIS | |||||||
| BOX 8118 660 S EUCLID AVE | ST LOUIS | MO | 63110 | 430653611 | 3 | 110000 | RESEARCH GRANT |
| WAYNE STATE UNIVERSITY | |||||||
| BARBARA ANN KARMANOS CANCER INSTIT | DETROIT | MI | 48201 | 386028429 | 3 | 200000 | RESEARCH GRANT |
| WHITEHEAD INSTITUTE FOR BIOMEDICAL | |||||||
| NINE CAMBRIDGE CENTER | CAMBRIDGE | MA | 02142 | 061043412 | 3 | 55000 | RESEARCH GRANT |
| WHITEHEAD INSTITUTE FOR BIOMEDICAL | |||||||
| NINE CAMBRIDGE CENTER | CAMBRIDGE | MA | 02142 | 061043412 | 3 | 55000 | RESEARCH GRANT |
| YALE UNIVERSITY | |||||||
| GRANT CONTRACT FINANCIAL ADMIN P | NEW HAVEN | CT | 065208250 | 060646973 | 3 | 55000 | RESEARCH GRANT |
| YALE UNIVERSITY | |||||||
| 333 CEDAR STREET PO BOX 208032 | NEW HAVEN | CT | 06520 | 060646973 | 3 | 200000 | RESEARCH GRANT |
| YALE UNIVERSITY | |||||||
| GRANT CONTRACT FINANCIAL ADMIN P | NEW HAVEN | CT | 065208250 | 060646973 | 3 | 55000 | RESEARCH GRANT |
| YALE UNIVERSITY | |||||||
| 10 AMISTAD STREET ROOM 414 | NEW HAVEN | CT | 06509 | 060646973 | 3 | 55000 | RESEARCH GRANT |
| YALE UNIVERSITY | |||||||
| BCMM 133 YALE UNIVERSITY 295 CONGR | NEW HAVEN | CT | 06519 | 060646973 | 3 | 55000 | RESEARCH GRANT |
| YALE UNIVERSITY | |||||||
| 333 CEDAR STREET PO BOX 208032 | NEW HAVEN | CT | 06520 | 060646973 | 3 | 110000 | RESEARCH GRANT |
| YALE UNIVERSITY | |||||||
| YALE UNIVERSITY BCMM 133 295 CONG | NEW HAVEN | CT | 06519 | 060646973 | 3 | 65000 | RESEARCH GRANT |
| OCONOVA | |||||||
| 375 PHEASANT RUN | NEWTON | PA | 18940 | 2000000 | THERAPY ACCELERATION | ||
| CELATOR | |||||||
| 303B COLLEGE ROAD EAST | PRINCETON | NJ | 08540 | 1817242 | THERAPY ACCELERATION | ||
| AVILA | |||||||
| 100 BEAVER STREET | WALTHAM | MA | 02453 | 961985 | THERAPY ACCELERATION | ||
| FORMA THERAPEUTICS | |||||||
| 790 MEMORIAL DRIVE | CAMBRIDGE | MA | 01239 | 950000 | THERAPY ACCELERATION | ||
| MEMGEN | |||||||
| 757 RAMBLER ROAD SUITE 700 | DALLAS | TX | 75231 | 837636 | THERAPY ACCELERATION | ||
| SHAPE | |||||||
| 55 CAMBRIDGE PARKWAY SUITE 102 | CAMBRIDGE | MA | 02142 | 600000 | THERAPY ACCELERATION | ||
| BIOTECHNOLOGY INNOVATION & OPTIMIZA | |||||||
| 2097 CONSTANT AVENUE | LAWRENCE | KS | 66047 | 321055 | THEREAPY ACCELERATIO | ||
| NANAOSYN | |||||||
| 3760 MAVEN AVENUE | MENLO PARK | CA | 94025 | 125000 | THERAY ACCELERATION | ||
| BECKLOFF ASSOCIATES INC | |||||||
| 3203 SOLUTIONS CENTER | CHICAGO | IL | 60677 | 62887 | THERAPY ACCELERATION | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Nbr Of501 C3 And Govt Grants | 300 | TotalNbrOf501C3AndGovtGrants |
| Total Nbr Of Other Organizations | 309 | TotalNbrOfOtherOrganizations |
Form990 Schedule I Part III Form990ScheduleIPartIII (7 entries)
| Type Of GrantTypeOfGrant | Number Of RecipientsNumberOfRecipients | Amount Of Cash GrantAmountOfCashGrant |
|---|---|---|
| PATIENT AID | 40351 | 6058760 |
| CO-PAY ASSISTANCE-AML | 40 | 112500 |
| CO-PAY ASSISTANCE-CML | 846 | 2103731 |
| CO-PAY ASSISTANCE-CLL | 832 | 1511000 |
| CO-PAY ASSISTANCE-LYMPHOM | 3010 | 5416000 |
| CO-PAY ASSISTANCE-MDS | 656 | 900000 |
| CO-PAY ASSISTANCE-MYELOMA | 2585 | 3960000 |
Form990 Schedule I Part IV Form990ScheduleIPartIV
| Field | Value | IRS element (for citing) |
|---|---|---|
| Identifier | PROCEDURES FOR MONITORING THE USE OF GRANT FUNDS INSIDE THE UNITED STATES | Identifier |
| Return Reference | SCHEDULE I, PAGE 1, PART I, LINE 2 | ReturnReference |
| Explanation | FIDUCIARY RESPONSIBILITY AND TRANSPARENCY TO OUR DONORS IS A HIGH PRIORITY. THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) PLACES CONSIDERABLE EMPHASIS ON THE OVERSIGHT OF GRANT SPENDING. TO ACCOMPLISH THIS WE REQUIRE THE SUBMISSION OF ANNUAL FINANCIAL REPORTS FOR EACH OF OUR ACTIVE GRANTS. THE REPORT MUST BE SIGNED BY THE FINANCIAL OFFICER AND/OR THE DESIGNATED OFFICIAL OF THE INSTITUTION HOSTING THE AWARD. AT THE END OF THE GRANT, WE REQUIRE A FINAL FINANCIAL REPORT THAT PROVIDES AN OVERVIEW OF ALL SPENDING THROUGH THE DURATION OF THE AWARD.WE REQUIRE SPECIFIC ACCOUNTING OF SPENDING ON PERSONNEL, CONSULTANTS,EQUIPMENT PURCHASES, SUPPLIES, TRAVEL, PATIENT CARE COSTS, ANIMAL CARE COSTS, AND ANY OTHER EXPENSE A GRANTEE MAY INCUR. WE HAVE SPECIFIC INSTRUCTIONS AND DOLLAR AMOUNT LIMITATIONS SET FOR MANY OF THESE CATEGORIES DEPENDING ON THE AWARD TYPE. FINANCIAL REPORTS ARE REVIEWED FOR NUMERICAL ACCURACY, ADHERENCE TO OUR GUIDELINES, AND FOR THE VERIFICATION OF APPROVAL FROM THE INSTITUTION'S FINANCIAL OFFICER. IF THE GRANTEE DOES NOT SUBMIT AN ANNUAL FINANCIAL REPORT BY THE DUE DATE OUTLINED IN THEIR CONTRACT, FUNDING IS SUSPENDED UNTIL LLS RECEIVES AND APPROVES THE DELINQUENT REPORT. | Explanation |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | X | CompensationCommittee |
| Compensation Survey | X | CompensationSurvey |
| Board Or Committee Approval | X | BoardOrCommitteeApproval |
| Severance Payment | true | SeverancePayment |
| Supplemental Nonqual Retire Plan | false | SupplementalNonqualRetirePlan |
| Equity Based Comp Arrangement | false | EquityBasedCompArrangement |
| Comp Based On Revenue Of Filing Org | true | CompBasedOnRevenueOfFilingOrg |
| Comp Based On Revenue Related Orgs | false | CompBasedOnRevenueRelatedOrgs |
| Comp Based Net Earnings Filing Org | false | CompBasedNetEarningsFilingOrg |
| Comp Based Net Earnings Relate Orgs | false | CompBasedNetEarningsRelateOrgs |
| Any Non Fixed Payments | false | AnyNonFixedPayments |
| Initial Contract Exception | false | InitialContractException |
Form990 Schedule J Part II Form990ScheduleJPartII (7 entries)
| Base Compensation Filing OrgBaseCompensationFilingOrg | Bonus Filing OrgBonusFilingOrg | Other Compensation Filing OrgOtherCompensationFilingOrg | Deferred Comp Filing OrgDeferredCompFilingOrg | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrg | Total Compensation Filing OrgTotalCompensationFilingOrg |
|---|---|---|---|---|---|
| JOHN WALTER | |||||
| 460417 | 45000 | 13082 | 30870 | 19241 | 568610 |
| JAMES T NANGLE | |||||
| 231456 | 6283 | 10282 | 23146 | 18763 | 289930 |
| LOUIS DEGENNERO PHD | |||||
| 299450 | 8129 | 8870 | 17150 | 13463 | 347062 |
| NANCY KLEIN | |||||
| 288975 | 8039 | 9514 | 24500 | 18879 | 349907 |
| BARTON KAMEN MD | |||||
| 129663 | 151270 | 17150 | 18907 | 316990 | |
| DAVID TIMKO | |||||
| 228375 | 6826 | 11813 | 22837 | 13374 | 283225 |
| JANE KARLIN | |||||
| 231120 | 5634 | 16178 | 13572 | 266504 | |
Form990 Schedule J Part III Form990ScheduleJPartIII (2 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| SEVERANCE, NONQUALIFIED, AND EQUITY-BASED PAYMENTS | SCHEDULE J, PAGE 1, PART I, LINE 4 | BARTON KAMEN, MD 141,450 0 0 |
| COMPENSATION CONTINGENT UPON REVENUES OF ORGANIZATION | SCHEDULE J, PAGE 1, PART I, LINE 5A | BONUSES WERE PAID BASED ON THE ACHIEVEMENT OF GROSS REVENUE EXCEEDING BUDGETED GROSS REVENUE AND EMPLOYEE INDIVIDUAL PERFORMANCE. BONUSES WERE CAPPED ACCORDING TO LLS'S POLICY. |
Schedule L IRS990ScheduleL
Form990 Schedule L Part III Form990ScheduleLPartIII
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Of Interested Person | DR ALAN GERWITZ | NameOfInterestedPerson |
| Relationship With Organization | BOD MEMBER | RelationshipWithOrganization |
| Amount Of Grant | 74159 | AmountOfGrant |
Form990 Schedule L Part IV Form990ScheduleLPartIV
Name Of Interested Person NameOfInterestedPerson
| Field | Value | IRS element (for citing) |
|---|---|---|
| Name Person | JAMES DAVIS | NamePerson |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Relationship | BOD MEMBER | Relationship |
| Amount Of Transaction | 307026 | AmountOfTransaction |
| Description Of Transaction | EQUITY IN AEGERA | DescriptionOfTransaction |
| Sharing Of Revenues | false | SharingOfRevenues |
Schedule M IRS990ScheduleM
Securities Publicly Traded SecuritiesPubliclyTraded
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | X | NonCashCheckbox |
| Number Of Contributions | 76 | NumberOfContributions |
| Noncash Contribs Rptd F990 | 412179 | NoncashContribsRptdF990 |
| Method Of Determining Revenues | MARKET VALUE | MethodOfDeterminingRevenues |
Food Inventory FoodInventory
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | X | NonCashCheckbox |
| Number Of Contributions | 28 | NumberOfContributions |
Other Non Cash Contributions Table OtherNonCashContributionsTable (3 entries)
| Non Cash CheckboxNonCashCheckbox | DescriptionDescription | Number Of ContributionsNumberOfContributions |
|---|---|---|
| X | PRINTING | 9 |
| X | FURNITURE&EQUIP | 9 |
| X | VARIOUS OTHERS | 51 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeld |
| Review Process Unusual NC Gifts | true | ReviewProcessUnusualNCGifts |
| Third Parties Used | true | ThirdPartiesUsed |
Form990 Schedule M Part II Form990ScheduleMPartII (3 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| THIRD PARTY USED TO PROCESS NONCASH CONTRIBUTIONS | SCHEDULE M, PAGE 1, PART I, LINE 32B | LLS USES ITS INVESTMENT CUSTODIAN TO LIQUIDATE ANY DONATED SECURITIES. |
| EXPLANATION FOR NOT REPORTING REVENUE | SCHEDULE M, PAGE 1, PART I, LINE 33 | LLS ONLY RECORDS DONATED SECURITIES AS REVENUE. ALL OTHER ITEMS FOR WHICH COLUMN A IS CHECKED ARE NOT RECORDED AS REVENUE OR EXPENSE BECAUSE THEY WOULD NOT HAVE BEEN PURCHASED HAD THEY NOT BEEN DONATED, AND ARE IMMATERIAL IN AMOUNT RELATIVE TO THE STATEMENTS OF LLS. |
| SUPPLEMENTAL INFORMATION | SCHEDULE M, PAGE 2, PART II | PART I, COLUMN (B) LLS IS REPORTING THE NUMBER OF CONTRIBUTIONS FOR EACH OF THE ITEMS IN PART I, NOT THE NUMBER OF INDIVIDUAL ITEMS. |
Schedule O IRS990ScheduleO
General Explanation GeneralExplanation (18 entries)
| IdentifierIdentifier | Return ReferenceReturnReference | ExplanationExplanation |
|---|---|---|
| FIRST ACHIEVEMENT DESCRIPTION | FORM 990, PAGE 2, PART III, LINE 4A | TO DATE, LLS HAS INVESTED MORE THAN 750 MILLION IN RESEARCH AIMED AT HELPING ALL BLOOD CANCER PATIENTS LIVE LONGER, HEALTHY LIVES. WE WILL CONTINUE TO SUPPORT RESEARCH THROUGH OUR INNOVATIVE AND INTEGRATED FUNDING PROGRAMS, UNTIL EVERY PATIENT HAS A SAFE AND EFFECTIVE THERAPY. IN FISCAL YEAR 2010, LLS SUPPORTED RESEARCH IN THE U.S., CANADA, AND 9 OTHER COUNTRIES.RESEARCH FUNDING WAS DISPERSED ACROSS ALL BLOOD CANCER CATEGORIES, INCLUDING: LEUKEMIA RESEARCH: APPROXIMATELY 25 MILLION LYMPHOMA RESEARCH: APPROXIMATELY 18 MILLION THERAPY ACCELERATION: APPROXIMATELY 8 MILLION BASIC BIOLOGY: APPROXIMATELY 6 MILLION MYELOMA RESEARCH: APPROXIMATELY 4 MILLION IMMUNOTHERAPY: APPROXIMATELY 4 MILLION STEM CELL: APPROXIMATELY 1 MILLION OUR CRITICAL ROLE LLS PROGRAMS ACCELERATE RELEVANT RESEARCH OUTCOMES BY: -BUILDING A FOCUSED RESEARCH WORK-FORCE: ASSURING THE NEXT ROUND OF BREAKTHROUGHS REQUIRES THAT YOUNG INVESTIGATORS BE ENCOURAGED TO WORK IN THE BLOOD CANCER RESEARCH FIELD. -TURNING DISCOVERIES INTO CLINICAL PROGRESS: BASIC SCIENCE DISCOVERIES MUST BE TRANSLATED INTO NEW, SAFE AND EFFECTIVE TREATMENTS THAT CAN ULTIMATELY PROLONG AND ENHANCE PATIENT LIVES. -SUPPORTING SYNERGY: LARGE GRANTS AND CONTRACTS ENABLE SCIENTISTS IN ACADEMIA AND THE PRIVATE-SECTOR TO COLLABORATE, COMBINING RESOURCES AND EXPERTISE TO PRODUCE MORE AND FASTER ADVANCES. -FILLING A VOID: RESEARCH PROJECTS THAT ARE HIGH-RISK OR ADDRESS RARE CANCERS ARE LESS LIKELY TO BE FUNDED BY THE GOVERNMENT OR BY FOR-PROFIT COMPANIES. LLS SUPPORTS MANY PROMISING PROJECTS THAT MIGHT OTHERWISE NEVER PROVIDE ADVANCES FOR THE BLOOD CANCER PATIENTS WHO NEED THEM. -INCREASING ACCESS TO CLINICAL TRIALS: PARTNERING WITH LEADING CLINICAL TRIAL CENTERS CAN ACCELERATE THE CLINICAL TESTING OF NEW BLOOD CANCER THERAPIES THAT ARE OFTEN A PATIENT'S BEST CHANCE FOR CURE. LLS ADMINISTERS TWO INTEGRATED RESEARCH FUNDING PROGRAMS, THE RESEARCH GRANT PROGRAM AND THE THERAPY ACCELERATION PROGRAM, TO SUPPORT OUR MISSION: CURE LEUKEMIA, LYMPHOMA, HODGKIN'S DISEASE AND MYELOMA, AND IMPROVE THE QUALITY OF LIFE OF PATIENTS AND THEIR FAMILIES. THE RESEARCH GRANT PROGRAM PROVIDES GRANT FUNDING TO SUPPORT SCIENTIFIC STUDIES AT ACADEMIC CENTERS AROUND THE WORLD, THROUGH THREE GRANT MECHANISMS: 1.THE CAREER DEVELOPMENT PROGRAM PROVIDES STIPENDS TO INVESTIGATORS OF EXCEPTIONAL PROMISE IN THE EARLY STAGES OF THEIR CAREERS, HELPING THEM TO DEVOTE THEIR CAREERS TO LEUKEMIA, LYMPHOMA AND/OR MYELOMA RESEARCH. SCHOLAR GRANTS ARE AWARDED AT 110,000 PER YEAR FOR A TOTAL OF 550,000 OVER FIVE YEARS. SPECIAL FELLOW GRANTS ARE AWARDED AT 65,000 PER YEAR FOR A TOTAL OF 195,000 OVER THREE YEARS. FELLOW GRANTS ARE AWARDED AT 55,000 PER YEAR FOR A TOTAL OF 165,000 OVER THREE YEARS. 2. THE TRANSLATIONAL RESEARCH PROGRAM SUPPORTS OUTSTANDING INVESTIGATIONS DEEMED BY OUR EXPERT ADVISORS MOST LIKELY TO TRANSLATE BASIC BIOMEDICAL DISCOVERIES INTO NEW, SAFE AND EFFECTIVE TREATMENTS, ULTIMATELY PROLONGING AND ENHANCING PATIENTS' LIVES. TRANSLATIONAL RESEARCH AWARDS ARE MADE FOR AN INITIAL THREE-YEAR PERIOD. AWARDS UP TO 200,000 PER YEAR FOR THREE YEARS, FOR A TOTAL OF 600,000 ARE GRANTED EACH YEAR. FUNDING FOR AN ADDITIONAL TWO YEARS MAY BE PROVIDED FOR HIGHLY PROMISING PROJECTS THAT ARE ENTERING PHASE I CLINICAL TRIAL. 3. THE SPECIALIZED CENTER OF RESEARCH PROGRAM ENCOURAGES MULTIDISCIPLINARY RESEARCH BY TEAMS OF LEADING-EDGE ACADEMIC INVESTIGATORS THAT HASTENS THE DISCOVERY AND DEVELOPMENT OF BETTER TREATMENTS FOR LEUKEMIA, LYMPHOMA AND MYELOMA PATIENTS. A CENTER IS COMPOSED OF AT LEAST THREE INDEPENDENT RESEARCH PROGRAMS THAT ARE INTEGRATED AND SUPPORTED BY SCIENTIFIC CORE LABORATORIES. EACH SPECIALIZED CENTER OF RESEARCH IS FUNDED UP TO 1.25 MILLION ANNUALLY OVER A FIVE-YEAR PERIOD, TO A TOTAL COST OF 6.25 MILLION. APPLICATION REVIEW PROCESS SCIENTISTS AND PHYSICIAN SCIENTISTS WHO ARE EXPERTS IN THE FIELD OF LEUKEMIA, LYMPHOMA, AND MYELOMA RESEARCH CAREFULLY EVALUATE ALL GRANT APPLICATIONS. GUIDELINES, INSTRUCTIONS, AND APPLICATIONS FOR LLS'S THREE RESEARCH PROGRAMS MAY BE OBTAINED BY VISITING WWW.LLS.ORG. THE THERAPY ACCELERATION PROGRAM (TAP) IS A STRATEGIC LLS INITIATIVE LAUNCHED IN 2007 WITH 4 MILLION IN SEED FUNDING. THIS PROGRAM PROMISES TO ACCELERATE NEW AND BETTER TREATMENTS AND CLINICAL TESTS INTO PRECLINICAL DEVELOPMENT AND CLINICAL TRIALS. WORKING IN CONCERT WITH ACADEMIC INVESTIGATORS, MEDICAL CENTERS, AND COMPANIES, TAP IS FURTHER BRIDGING THE GAP BETWEEN DISCOVERY AND HUMAN APPLICATIONS TO INCREASE THE LIKELIHOOD THAT NOVEL, POSSIBLY BREAKTHROUGH, TREATMENTS WILL BE MADE AVAILABLE TO PATIENTS AS SOON AS POSSIBLE. TAP ENCOMPASSES THREE INNOVATIVE EFFORTS: 1.THE ACADEMIC CONCIERGE DIVISION IDENTIFIES CURRENT LLS-FUNDED RESEARCH WITH THE GREATEST CLINICAL PROMISE AND PROVIDES THE FUNDING AND SUPPORT NEEDED TO ADVANCE SELECTED PROJECTS TO THE PRODUCT STAGE. 2.THE CLINICAL TRIAL DIVISION PARTNERS LLS WITH CERTAIN OF THE COUNTRY'S LEADING CLINICAL TRIAL CENTERS TO ACCELERATE THE TESTING OF NEW BLOOD CANCER THERAPIES IN CLINICAL TRIALS. 3.THE BIOTECHNOLOGY ACCELERATOR DIVISION ALLIES LLS WITH COMPANIES TO COMBINE SCIENTIFIC AND FINANCIAL RESOURCES AND ACCELERATE THE DEVELOPMENT OF POTENTIAL THERAPIES WHICH WOULDN'T OTHERWISE BE PRIORITIZED BY THE COMPANY. APPLICATION REVIEW PROCESS ALL THERAPY ACCELERATION PROJECTS ARE REVIEWED AND APPROVED BY A VOLUNTEER PANEL INCLUDING MEDICAL, SCIENTIFIC, BUSINESS, AND INTELLECTUAL PROPERTY LAW EXPERTS. FUNDING IS GOVERNED BY A CONTRACT WITH EXPLICIT TIMELINES, MILESTONES, AND GO/NO GO DECISION POINTS, WHICH ALSO CONTEMPLATES A RETURN ON INVESTMENT FOR LLS. GUIDELINES, INSTRUCTIONS, AND APPLICATIONS FOR THE THERAPY ACCELERATION PROGRAM MAY BE OBTAINED BY VISITING WWW.LLS.ORG. |
| SECOND ACHIEVEMENT DESCRIPTION | FORM 990, PAGE 2, PART III, LINE 4B | -TELECONFERENCES & WEBCASTS: LLS SPONSORS TELECONFERENCES AND WEB CASTS FOR PATIENTS, CAREGIVERS, SURVIVORS AND HEALTH CARE PROFESSIONALS ON LEUKEMIA, LYMPHOMA, MYELOMA AND MYELODYSPLASTIC SYNDROMES. A CALENDAR OF THESE FREE EVENTS AND ARCHIVES OF PAST EVENTS ARE AVAILABLE IN THE "NATIONAL EDUCATION PROGRAMS" SECTION OF WWW.LLS.ORG. 438,105 TELEPHONE AND WEB-BASED PROGRAM PARTICIPANTS IN 2010 -EDUCATIONAL MATERIALS: AN EXTENSIVE COLLECTION OF EDUCATIONAL MATERIALS IS OFFERED FREE-OF-CHARGE TO PATIENTS AND HEALTH CARE PROFESSIONALS. EACH YEAR, LLS DISTRIBUTES BOOKLETS, BROCHURES, FACT SHEETS AND DVDS THROUGH THE INFORMATION RESOURCE CENTER AND LOCAL LLS CHAPTERS. 1,207,000 PRINTED BOOKLETS, BROCHURES, FACT SHEETS AND DVDS DISTRIBUTED IN 2010 MANY MATERIALS ARE ALSO AVAILABLE TO VIEW AND DOWNLOAD AT WWW.LLS.ORG/FREEMATERIALS. DOWNLOADABLE MATERIALS ARE AVAILABLE IN ENGLISH,SPANISH AND FRENCH. -CHAPTER-BASED PROGRAMS: EACH LLS CHAPTER IS STAFFED WITH A PATIENT SERVICES MANAGER WHO OVERSEES THE CHAPTER'S SERVICES TO PATIENTS AND THEIR FAMILIES. PATIENT SERVICES MANAGERS ARE HEALTHCARE PROFESSIONALS, OFTEN WITH A BACKGROUND IN ONCOLOGY NURSING OR SOCIAL WORK. -COMMUNITY BASED EDUCATION: 42,848 PATIENT AND CAREGIVER PARTICIPANTS IN 2010 11,953 HEALTHCARE PROFESSIONAL PARTICIPANTS IN 2010 EACH OF THE FOLLOWING FOUR PROGRAMS ARE OFFERED THROUGH ALL OF OUR CHAPTERS. 1.NEW DIRECTIONS IN BLOOD CANCER THERAPIES THIS PROGRAM PROVIDES PATIENTS, FAMILIES AND HEALTHCARE PROFESSIONALS WITH A CLEAR DESCRIPTION OF WHAT CLINICAL TRIALS ARE, HOW CANCER DRUGS ARE DEVELOPED, AND WHAT THE EMERGING TREATMENT OPTIONS ARE FOR LEUKEMIA, LYMPHOMA,AND MYELOMA. 2.LIVING WITH MYELOMA: AN OVERVIEW OF DIAGNOSIS AND TREATMENT THIS PROGRAM PROVIDES PATIENTS, FAMILY MEMBERS AND CAREGIVERS WITH THE LATEST INFORMATION ON MYELOMA AND MYELOMA THERAPY, INCLUDING A QUESTION AND ANSWER SESSION WITH A MEDICAL EXPERT IN THEIR COMMUNITY. 3.GETTING THE BEST CANCER CARE AT AGE 55 AND OLDER THIS EDUCATION PROGRAM PRESENTS AN OVERVIEW OF THE MANY FACTORS, NOT AGE ALONE, THAT HEALTHCARE PROFESSIONALS SHOULD ASSESS TO DETERMINE AN APPROPRIATE CANCER TREATMENT PLAN FOR AN OLDER ADULT. 4.WELCOME BACK: FACILITATING THE SCHOOL EXPERIENCE FOR CHILDHOOD CANCER SURVIVOR THIS EDUCATION PROGRAM DISCUSSES POSSIBLE EMOTIONAL AND COGNITIVE SHORT- AND LONG-TERM EFFECTS THAT CHILDREN MAY EXPERIENCE AFTER TREATMENT, AND OFFERS NUMEROUS RESOURCES THAT CAN ASSIST CHILDHOOD CANCER SURVIVORS TO FLOURISH IN THE SCHOOL POST TREATMENT. -SUPPORT SERVICES: 1.FAMILY SUPPORT GROUPS LLS HAS DEVELOPED NEARLY 531 FAMILY SUPPORT GROUPS AT CHAPTERS THROUGHOUT THE US AND CANADA. LLS ALSO HAS MORE THAN 930 VOLUNTEER SUPPORT GROUP FACILITATORS WITH BACKGROUNDS IN ONCOLOGY NURSING OR SOCIAL WORK. GROUPS ARE GUIDED BY TWO VOLUNTEER ONCOLOGY HEALTH PROFESSIONALS, AND PROVIDE INFORMATION AND SUPPORT, AND ENCOURAGE GREATER COMMUNICATION AMONG PATIENTS, FAMILIES, FRIENDS AND HEALTH CARE PROFESSIONALS. 10,420 PARTICIPANTS IN FAMILY SUPPORT GROUPS IN 2010 2.FIRST CONNECTION FIRST CONNECTION IS A PROGRAM THAT LINKS NEWLY DIAGNOSED PATIENTS TO A PEER VOLUNTEER WHO HAS EXPERIENCED A SIMILAR DIAGNOSIS. A TRAINED PATIENT-VOLUNTEER CURRENTLY IN REMISSION CONTACTS THE NEW PATIENT TO SHARE INFORMATION AND SUPPORT. THIS PROGRAM IS AVAILABLE THROUGH LLS CHAPTERS. 5,376 FIRST CONNECTIONS IN 2010 3.PATIENT FINANCIAL AID PROGRAM FOR MORE THAN 45 YEARS, LLS HAS HELPED PATIENTS DEMONSTRATING SIGNIFICANT NEED TO OBTAIN FINANCIAL ASSISTANCE TO COVER A PORTION OF THEIR TREATMENT COSTS. THE LLS PATIENT FINANCIAL AID PROGRAM OFFERS 150 PER YEAR TO THOSE WITH A CONFIRMED BLOOD CANCER DIAGNOSIS IN ACTIVE TREATMENT OR ONGOING FOLLOW-UP. PATIENT FINANCIAL AID FUNDS ARE SUBJECT TO AVAILABILITY. 40,392 PATIENT FINANCIAL AID RECIPIENTS IN 2010 4.CO-PAY ASSISTANCE PROGRAM THIS ASSISTANCE PROGRAM HELPS PATIENTS WITH MANY KINDS OF BLOOD CANCERS MEET THEIR HEALTH INSURANCE OR MEDICARE PLAN PART B OR D PREMIUMS OR CO-PAYMENT OBLIGATIONS RELATED TO TREATING THEIR CANCER. PATIENTS WITH PRESCRIPTION DRUG COVERAGE, MEDICARE BENEFICIARIES UNDER MEDICARE PART B AND/OR MEDICARE PART D, MEDICARE SUPPLEMENTARY HEALTH INSURANCE OR MEDICARE ADVANTAGE SHOULD CHECK WITH LLS TO SEE IF THEY MEET ELIGIBILITY REQUIREMENTS TO RECEIVE FINANCIAL SUPPORT. CO-PAY ASSISTANCE IS SUBJECT TO FUND AVAILABILITY BY SPECIFIC BLOOD CANCER DIAGNOSIS. FOR MORE INFORMATION CALL, (877) LLS-COPAY (877) 557-2672 OR VISIT WWW.LLS.ORG/COPAY. 5536 PATIENTS RECEIVED LLS CO-PAY ASSISTANCE IN 2010 5.THE TRISH GREENE BACK TO SCHOOL PROGRAM FOR CHILDREN WITH CANCER THIS PROGRAM IS DESIGNED TO INCREASE COMMUNICATION AMONG HEALTH CARE PROFESSIONALS, PARENTS, PATIENTS AND SCHOOL PERSONNEL TO ASSURE YOUNGSTERS A SMOOTH TRANSITION FROM ACTIVE TREATMENT BACK TO SCHOOL. PRINTED LITERATURE, VIDEOS AND OTHER MATERIALS TO AID THE PROCESS ARE AVAILABLE THROUGH ALL LOCAL CHAPTERS, INCLUDING: -WELCOME BACK: FACILITATING THE SCHOOL EXPERIENCE FOR CHILDHOOD CANCER SURVIVORS CHAPTER EDUCATION PROGRAM. THIS EDUCATION PROGRAM FOR SCHOOL PERSONNEL AND PARENTS DISCUSSES POSSIBLE EMOTIONAL AND COGNITIVE LATE EFFECTS OF CANCER TREATMENT IN CHILDREN AND OFFERS NUMEROUS RESOURCES THAT CAN ASSIST CHILDHOOD CANCER SURVIVORS TO FLOURISH IN THE SCHOOL ENVIRONMENT POST-TREATMENT. IN FISCAL YEAR 2010 2,609 SCHOOL PERSONNEL, HEALTHCARE PROFESSIONALS AND PARENTS PARTICIPATED IN THE 67 WELCOME BACK PROGRAMS ACROSS THE USA AND CANADA. -LEARNING AND LIVING WITH CANCER,ADVOCATING FOR YOUR CHILD'S EDUCATIONAL NEEDS: THIS BOOKLET OFFERS PARENTS INFORMATION ON THE LEARNING CHALLENGES CHILDREN MAY FACE DURING AND AFTER CANCER TREATMENT, LAWS THAT PROTECT THE EDUCATIONAL NEEDS OF CHILDREN WITH CANCER AND SPECIFIC WAYS THAT SCHOOLS CAN HELP MEET A CHILD'S EDUCATIONAL NEEDS. |
| THIRD ACHIEVEMENT DESCRIPTION | FORM 990, PAGE 2, PART III, LINE 4C | FACT SHEETS FOR FREQUENTLY ASKED QUESTIONS AND A REFERRAL DATABASE TO OTHER HELPING ORGANIZATIONS ARE AVAILABLE. PATIENTS, FAMILIES AND PROFESSIONALS MAY CALL THE INFORMATION RESOURCE CENTER TOLL-FREE NUMBER AT (800) 955-4572 MONDAY THROUGH FRIDAY, 9 A.M. TO 6 P.M., ET OR EMAIL TO INFOCENTER@LLS.ORG. 77,159 INQUIRIES IN 2010 TRANSLATION SERVICES AVAILABLE IN MORE THAN 165 LANGUAGES ONLINE ENGAGEMENT THE LLS WEBSITE SERVES A WIDE VARIETY OF EDUCATION AND INFORMATION NEEDS. USERS CAN PERSONALIZE THEIR LLS WEB PAGES TO KEEP CURRENT WITH DISEASE SPECIFIC UPDATES AND LOCAL CHAPTER EDUCATION, SUPPORT AND EVENT ACTIVITIES. THE SITE FEATURES A COMPREHENSIVE OVERVIEW OF LLS PROGRAMS AND SERVICES, FAMILY SUPPORT GROUP LOCATIONS, INFORMATION ABOUT OUR PEER-TO-PEER PROGRAM "FIRST CONNECTION", AND OTHER PROGRAMS. PATIENTS, CAREGIVERS AND HEALTHCARE PROFESSIONALS CAN INTERACT WITH LLS IN CONVENIENT AND PERSONAL WAYS THROUGH SOCIAL NETWORKING, PODCASTS AND ENEWSLETTERS. 3.6 MILLION UNIQUE VISITS TO PATIENT SERVICES/DISEASE INFORMATION PAGES IN 2010 176,847 ENEWSLETTER SUBSCRIBERS 113,493 BLOOD CANCER DISCUSSION BOARDS UNIQUE VISITS 103,994 TELECONFERENCE PODCASTS DOWNLOADS |
| ALL OTHER ACHIEVEMENTS DESCRIPTION | FORM 990, PAGE 2, PART III, LINE 4D | D) PROFESSIONAL EDUCATION: LLS ALSO SERVES THE EDUCATIONAL NEEDS OF THE MEDICAL AND RESEARCH COMMUNITY THROUGH A NUMBER OF PROFESSIONAL EDUCATION SYMPOSIA OFFERED THROUGHOUT THE YEAR. THE EDUCATIONAL PROGRAM OFFERS VARYING FORMATS TO FACILITATE THE EXCHANGE OF INFORMATION AND IDEAS ON THE NEWEST DEVELOPMENTS IN CANCER RESEARCH AND TREATMENT. |
| FINANCIAL ACCOUNTS IN FOREIGN COUNTRIES | FORM 990, PART V, LINE 4B | CANADA |
| CLASSES OF MEMBERS OR STOCKHOLDERS | FORM 990, PAGE 6, PART VI, LINE 6 | THE MEMBERS OF LLS CONSIST OF ONE ELECTED REPRESENTATIVE FROM EACH CHAPTER. |
| ELECTION OF MEMBERS AND THEIR RIGHTS | FORM 990, PAGE 6, PART VI, LINE 7A | THE BOARD OF REPRESENTATIVES (REPRESENTING THE CHAPTERS) ELECTS THE MEMBERS OF LLS'S GOVERNING BODY, ITS NATIONAL BOARD OF DIRECTORS. |
| DECISIONS SUBJECT TO APPROVAL OF MEMBERS | FORM 990, PAGE 6, PART VI, LINE 7B | SIGNIFICANT DECISIONS AFFECTING THE CHAPTERS REQUIRE AN APPROVING VOTE BY THE CHAPTER DELEGATES. DECISIONS NOT SIGNIFICANTLY AFFECTING THE CHAPTERS DO NOT REQUIRE APPROVAL FROM THE CHAPTER DELEGATES. |
| POLICIES AND PROCEDURES GOVERNING CHAPTERS | FORM 990, PAGE 6, PART VI, LINE 10B | LLS HAS ONE SET OF WRITTEN POLICIES AND PROCEDURES THAT GOVERN ALL OF OUR CHAPTERS AND OUR NATIONAL OFFICE. |
| ORGANIZATION'S PROCESS USED TO REVIEW FORM 990 | FORM 990, PAGE 6, PART VI, LINE 11 | THE FORM 990 WAS PREPARED BY THE LLS FINANCE DEPARTMENT AND WAS REVIEWED BY THE CFO, VICE PRESIDENT OF FINANCE, AND KPMG FOR COMMENT AND SUGGESTED REVISIONS. THE FORM 990 WAS THEN PROVIDED TO THE AUDIT COMMITTEE, WHICH IS A COMMITTEE OF THE BOARD OF DIRECTORS. THE AUDIT COMMITTEE REVIEWED THE 990 AND PROVIDED INPUT PRIOR TO FILING. THE FINAL DRAFT FORM 990 WAS MADE AVAILABLE TO THE ENTIRE BOARD OF DIRECTORS PRIOR TO FILING BY POSTING THE FORM ON AN INTRANET WEBSITE. |
| ENFORCEMENT OF CONFLICTS POLICY | FORM 990, PAGE 6, PART VI, LINE 12C | ALL EMPLOYEES, BOARD OF DIRECTORS MEMBERS, BOARD OF REPRESENTATIVES MEMBERS, CHAPTER BOARD MEMBERS, FAMILY SUPPORT GROUP FACILITATORS, AND TNT COACHES ARE REQUIRED TO REVIEW THE CONFLICT OF INTEREST POLICY ON AN ANNUAL BASIS AND SUBMIT A SIGNED FORM ACKNOWLEDGING THAT THEY HAVE REVIEWED THE POLICY AND DISCLOSED ANY CONFLICTS OF INTEREST. ALL FORMS ARE COLLECTED AND THE AUDIT COMMITTEE REVIEWS ANY FORMS DISCLOSING A POSSIBLE CONFLICT OF INTEREST AND DETERMINES WHETHER OR NOT A CONFLICT EXISTS. |
| COMPENSATION PROCESS FOR TOP OFFICIAL | FORM 990, PAGE 6, PART VI, LINE 15A | THE EXECUTIVE COMMITTEE, COMPRISED OF INDEPENDENT MEMBERS OF THE BOARD OF DIRECTORS, REVIEWS AND MONITORS THE CHIEF EXECUTIVE OFFICER'S PERFORMANCE AND COMPENSATION. THE COMMITTEE OBTAINED A SURVEY OF OTHER NOT-FOR-PROFIT ORGANIZATIONS' COMPENSATION RANGES AND SET THE CHIEF EXECUTIVE'S SALARY COMMENSURATELY. THE REVIEW WAS DOCUMENTED IN THE EXECUTIVE COMMITTEE'S MINUTES. |
| COMPENSATION PROCESS FOR OFFICERS | FORM 990, PAGE 6, PART VI, LINE 15B | THE EXECUTIVE COMMITTEE, COMPRISED OF INDEPENDENT MEMBERS OF THE BOARD OF DIRECTORS, REVIEWED A SURVEY OF OTHER NOT-FOR-PROFIT ORGANIZATIONS' COMPENSATION RANGES AND COMPARED THIS TO THE OTHER OFFICER'S SALARY AND DETERMINED THAT IT WAS APPROPRIATE. THE REVIEW WAS DOCUMENTED IN THE EXECUTIVE COMMITTEE'S MINUTES. |
| STATES WHERE COPY OF RETURN IS FILED | FORM 990, PAGE 6, PART VI, LINE 17 | ALASKA, ARKANSAS, ARIZONA, CALIFORNIA, CONNECTICUT, DELAWARE, FLORIDA, GEORGIA, ILLINOIS, INDIANA, KANSAS, KENTUCKY, LOUISIANA, MASSACHUSETTS, MARYLAND, MAINE, MICHIGAN, MINNESOTA, MISSOURI, MISSISSIPPI, NEW HAMPSHIRE, NEW JERSEY, NEW MEXICO, NEVADA, NEW YORK, OHIO, OKLAHOMA, OREGON, PENNSYLVANIA, PUERTO RICO, RHODE ISLAND, SOUTH CAROLINA, TENNESSEE, UTAH, VIRGINIA, WASHINGTON, WISCONSIN, WEST VIRGINIA |
| GOVERNING DOCUMENTS DISCLOSURE EXPLANATION | FORM 990, PAGE 6, PART VI, LINE 19 | THE LEUKEMIA & LYMPHOMA SOCIETY, INC. MAKES ITS ANNUAL FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC ON ITS WEBSITE AT WWW.LLS.ORG. ITS GOVERNING DOCUMENTS ARE MADE AVAILABLE, WHEN CHANGES ARE MADE, AS PART OF THE 990 AVAILABLE FOR PUBLIC INSPECTION. ANY IDENTIFIED CONFLICTS OF INTEREST ARE DISCLOSED IN THE 990. |
| STATES WITH GAMING OPERATIONS | SCHEDULE G, PAGE 2, PART III, LINE 9 | CALIFORNIA, CONNECTICUT, FLORIDA, LOUISIANA, MARYLAND, MICHIGAN, MINNESOTA, NEW YORK, OHIO, PENNSYLVANIA, RHODE ISLAND, TEXAS, WISCONSIN, ARIZONA, GEORGIA, MASSACHUSETTS, DIST OF COLUMBIA, NEW JERSEY, NEVADA, VIRGINIA, WASHINGTON |
| GROUP EXEMPTION RELATIONSHIPS | SCHEDULE R | SCHEDULE R, PART II, COLUMN B - THE LEUKEMIA & LYMPHOMA SOCIETY OF CANADA CARRIES OUT THE SAME PRIMARY ACTIVITIES AS THE LEUKEMIA & LYMPHOMA SOCIETY,INC., IN CANADA. THE LEUKEMIA & LYMPHOMA SOCIETY RESEARCH PROGRAMS,INC. AND THE LEUKEMIA & LYMPHOMA SOCIETY RESEARCH FOUNDATION SUPPORT THE ACTIVITIES OF THE LEUKEMIA & LYMPHOMA SOCIETY, INC. |
| ADDITIONAL INFORMATION | SCHEDULE O | PART IV, LINE 12 - THE AUDITED FINANCIAL STATEMENTS FOR THE LEUKEMIA & LYMPHOMA SOCIETY, INC. INCLUDE THE LEUKEMIA & LYMPHOMA SOCIETY OF CANADA, THE LEUKEMIA & LYMPHOMA SOCIETY RESEARCH PROGRAMS, INC., AND THE LEUKEMIA & LYMPHOMA SOCIETY RESEARCH FOUNDATION IN ADDITION TO LLS. SCHEDULE G, PART I, LINE 2B - LLS USED INFOCISION, HAINES & CO., AND THOMPSON HABIB DENISON FOR ITS NATIONAL COMMUNITY CAMPAIGN AND DIRECT MAIL PROGRAMS.THESE PROGRAMS GENERATED GROSS RECEIPTS OF 29,088,073 DURING FISCAL YEAR 2010. LLS USED DIRECT PRINT COMMUNICATIONS, PARADYSZ MATERA, AND PIDI FOR ALL OF ITS OTHER FUNDRAISING EVENTS. PART VII, SECTION B, LINE 1 - THE VENDORS INCLUDED HERE ARE USED FOR THE NATIONAL COMMUNITY CAMPAIGN AND DIRECT MAIL PROGRAMS. MSP IS A PRINTING COMPANY,PARADYZ MATERA PROVIDES ADDRESS LISTS, INFOCISION DOES TELEMARKETING, AND DIRECT PRINT COMMUNICATIONS PROVIDES PRINTING AND MAILING SERVICES. AT LEAST THREE BIDS ARE OBTAINED FOR THESE SERVICES ON AN ANNUAL BASIS. |
Schedule R IRS990ScheduleR
Form990 Schedule R Part II Form990ScheduleRPartII (3 entries)
| Address Line1AddressForeign/AddressLine1 | CityAddressForeign/City | CountryAddressForeign/Country | Postal CodeAddressForeign/PostalCode | Primary ActivitiesPrimaryActivities | Legal Domicile Foreign CountryLegalDomicileForeignCountry | Business Name Line1DirectControllingEntityName/BusinessNameLine1 | Address Line1AddressUS/AddressLine1 | CityAddressUS/City | StateAddressUS/State | ZIP CodeAddressUS/ZIPCode | EINEIN | Legal Domicile StateLegalDomicileState | Exempt Code SectionExemptCodeSection | Public Charity StatusPublicCharityStatus |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| THE LLS OF CANADA | ||||||||||||||
| 804-2 LANSING SQUARE | TORONTO | CA | M2J4P8 | SCHED O | CA | NA | ||||||||
| THE LLS RESEARCH PROGRAMS INC | ||||||||||||||
| SCHED O | NA | 1311 MAMARONECK AVENUE | WHITE PLAINS | NY | 10605 | 133470494 | DE | 501 | 11B | |||||
| THE LLS RESEARCH FOUNDATION | ||||||||||||||
| SCHED O | NA | 1311 MAMARONECK AVENUE | WHITE PLAINS | NY | 10605 | 133709252 | DE | 501 | 11B | |||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Ann Rents Royalties | false | ReceiptOfIntAnnRentsRoyalties |
| Gift Grant Or Cap Contr To Other Org | false | GiftGrantOrCapContrToOtherOrg |
| Gift Grant Or Cap Contr Fr Other Org | true | GiftGrantOrCapContrFrOtherOrg |
| Loans Or Guarantees To Other Org | true | LoansOrGuaranteesToOtherOrg |
| Loans Or Guarantees From Other Org | false | LoansOrGuaranteesFromOtherOrg |
| Sale Of Assets To Other Org | false | SaleOfAssetsToOtherOrg |
| Purchase Of Assets From Other Org | false | PurchaseOfAssetsFromOtherOrg |
| Exchange Of Assets | false | ExchangeOfAssets |
| Rental Of Facilities To Other Orgs | false | RentalOfFacilitiesToOtherOrgs |
| Rental Of Facilities Fr Other Orgs | false | RentalOfFacilitiesFrOtherOrgs |
| Perform Of Services For Other Orgs | false | PerformOfServicesForOtherOrgs |
| Perform Of Services By Other Orgs | false | PerformOfServicesByOtherOrgs |
| Sharing Of Facilities | true | SharingOfFacilities |
| Sharing Of Paid Employees | true | SharingOfPaidEmployees |
| Reimbursement Paid To Other Org | false | ReimbursementPaidToOtherOrg |
| Reimbursement Paid By Other Org | false | ReimbursementPaidByOtherOrg |
| Other Transfer To Other Org | false | OtherTransferToOtherOrg |
| Other Transfer From Other Org | false | OtherTransferFromOtherOrg |
Transactions Related Orgs Table TransactionsRelatedOrgsTable (2 entries)
| Transaction TypeTransactionType | Amount InvolvedAmountInvolved |
|---|---|
| THE LEUKEMIA & LYMPHOMA SOCIETY | |
| D | 210113 |
| OF CANADA | |
Comments